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Abstract
Sleep is an important physiological state, but its function and regulation remain elusive. In Drosophila
melanogaster, a useful model organism for studying sleep, forward genetic screens have identified
important sleep-modulating genes and pathways; however, the results of such screens may be limited by
developmental abnormalities or lethality associated with mutation of certain genes. To circumvent these
limitations, we screened 1280 small molecules for effects on sleep in adult Drosophila. We used genetic
and molecular approaches to elucidate the mechanisms by which two of these drugs altered sleep
behavior.
We found that administration of reserpine, a small molecule inhibitor of the vesicular monoamine
transporter (VMAT) that repackages monoamines into presynaptic vesicles, resulted in an increase in
sleep. We found that VMAT-null mutants, like reserpine-fed flies, have an increased sleep phenotype, as
well as an increased arousal threshold and resistance to the effects of reserpine. However, although the
VMAT mutants are consistently resistant to reserpine, other aspects of their sleep phenotype are
dependent on genetic background. Thus, they may not have been detected in a classical forward genetic
screen, further attesting to the utility of a small molecule screen. Mutations affecting single monoamine
pathways did not affect reserpine sensitivity, suggesting that effects of VMAT/reserpine on sleep are
mediated by multiple monoamines.
We also studied the mode of action of caffeine, a common wake-promoting compound. Caffeine is
thought to promote wake by inhibiting adenosine receptors, however previous work demonstrated that
the wake-promoting effects of caffeine are independent of the adenosine receptor in the fly. We show that
dopamine is required for the wake-promoting effect of caffeine in the fly, and that caffeine likely acts
presynaptically to increase dopamine signaling. We identify a cluster of neurons, the paired anterior
medial (PAM) cluster of dopaminergic neurons, which are essential for the caffeine response and which
show increased activity following caffeine administration.
Overall, we find that small molecule screens can be used effectively to identify regulators of adult
behavior. The results of our screen and follow-up experiments demonstrate that presynaptic modulation
of monoamine signaling may be a major source of sleep regulation.
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ABSTRACT
UPPERS AND DOWNERS: UNDERSTANDING SLEEP
REGULATION USING SMALL MOLECULES IN DROSOPHILA
Aleksandra Nall
Amita Sehgal, Ph.D.

Sleep is an important physiological state, but its function and regulation remain elusive. In
Drosophila melanogaster, a useful model organism for studying sleep, forward genetic screens
have identified important sleep-modulating genes and pathways; however, the results of such
screens may be limited by developmental abnormalities or lethality associated with mutation of
certain genes. To circumvent these limitations, we screened 1280 small molecules for effects on
sleep in adult Drosophila. We used genetic and molecular approaches to elucidate the
mechanisms by which two of these drugs altered sleep behavior.
We found that administration of reserpine, a small molecule inhibitor of the vesicular
monoamine transporter (VMAT) that repackages monoamines into presynaptic vesicles, resulted
in an increase in sleep. We found that VMAT-null mutants, like reserpine-fed flies, have an
increased sleep phenotype, as well as an increased arousal threshold and resistance to the
effects of reserpine. However, although the VMAT mutants are consistently resistant to reserpine,
other aspects of their sleep phenotype are dependent on genetic background. Thus, they may not
have been detected in a classical forward genetic screen, further attesting to the utility of a small
molecule screen. Mutations affecting single monoamine pathways did not affect reserpine
sensitivity, suggesting that effects of VMAT/reserpine on sleep are mediated by multiple
monoamines.
We also studied the mode of action of caffeine, a common wake-promoting compound.
Caffeine is thought to promote wake by inhibiting adenosine receptors, however previous work
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demonstrated that the wake-promoting effects of caffeine are independent of the adenosine
receptor in the fly. We show that dopamine is required for the wake-promoting effect of caffeine
in the fly, and that caffeine likely acts presynaptically to increase dopamine signaling. We identify
a cluster of neurons, the paired anterior medial (PAM) cluster of dopaminergic neurons, which are
essential for the caffeine response and which show increased activity following caffeine
administration.
Overall, we find that small molecule screens can be used effectively to identify regulators
of adult behavior. The results of our screen and follow-up experiments demonstrate that
presynaptic modulation of monoamine signaling may be a major source of sleep regulation.
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INTRODUCTION
Published: Nall A, Sehgal A. (2014) Monoamines and sleep in Drosophila. Behav Neurosci,
128(3):264-72.

Sleep is an important physiological state that has been observed in most well-studied
animals. Many such animals have been used as models to study the genetic and molecular
mechanisms underlying sleep regulation in an attempt to understand how and why we sleep.
From all of these studies, it has become clear that sleep is controlled by the circadian clock and
by a homeostatic mechanism (Borbély, 1982). The circadian clock communicates time-of-day
information inferred from light and temperature cues to ensure that sleep occurs during the right
times of day. The sleep homeostat keeps track of the duration of sleep and wake to ensure that
daily sleep need is met.
Much of our understanding of circadian clock mechanisms has come from the fruit fly,
Drosophila melanogaster. Clock genes and mechanisms discovered in Drosophila were found to
be conserved in humans, underscoring how much we can learn about ourselves from these tiny
insects (Cirelli, 2009; Crocker & Sehgal, 2010; Sehgal & Mignot, 2011). A Drosophila model for
the homeostatic regulation of sleep has been established to exploit the genetic tractability and
ease of high-throughput behavioral testing that these animals provide (Hendricks et al., 2000;
Shaw et al., 2000). Drosophila sleep shares many similarities with human sleep, including diurnal
distribution of sleep/wake activity, a homeostatic reaction to sleep deprivation, and an increased
arousal threshold (i.e., reduced responsiveness to sensory stimulation) during sleep. It follows,
then, that these behavioral states are likely regulated similarly, and the fly will be an invaluable
tool in understanding our own drive to sleep.
Like other behaviors, including learning, courtship, aggression, and social behaviors,
sleep is modulated by experience and environment in addition to being driven by intrinsic
mechanisms. Signals in the brain integrate the various inputs to generate a coordinated output
that governs successful behavior. These signals take the form of hormones, neuropeptides,
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neurotransmitters, and neuromodulators, which can respond to external and physiological cues.
Given that sleep involves widespread changes in brain activity, it is easy to see how modulators
of neural activity are important in its regulation. For example, one of the canonical characteristics
of sleep is an increased arousal threshold, which refers to lack of a response to a stimulus that
elicits a response in an awake animal. One way that circuit-wide changes in neuronal excitability
can be achieved is by neuromodulation, in which biogenic amines and other neuromodulators
diffuse through the brain and affect general brain activity. My thesis work has demonstrated that
two drugs that alter sleep behavior do so by modulating the signaling of one class of
neuromodulators, monoamines. Therefore, this introduction focuses on what we currently know
about the regulation of sleep and circadian rhythms by monoamine signaling, with a focus on
knowledge gained from the Drosophila model.
Sleep and Monoamines
Neuromodulators involved in fine-tuning neuronal excitability, as well as direct synaptic
transmission, are the monoamines. This class of neuromodulators includes dopamine, serotonin,
norepinephrine and its invertebrate analog octopamine, histamine, and the trace amine tyramine.
The most abundant monoamines in the Drosophila nervous system are dopamine, octopamine,
and serotonin. These monoamines have conserved biosynthetic pathways (Livingstone &
Tempel, 1983) and conserved effects on many behaviors. Recently, all of these monoamines
have also been found to regulate sleep behavior at the circadian and homeostatic level.
Dopamine, octopamine, and serotonin function in disparate and overlapping anatomical brain
regions to integrate environmental information (e.g., light, social cues, and food abundance) to
ensure appropriate timing and quantity of sleep. In addition, histamine acts in Drosophila to inhibit
sleep, much as it is known to do in mammals.
Dopamine
One of the earliest sleep mutants identified in the Drosophila model implicated dopamine
signaling in sleep regulation. This mutant, called fumin, sleeps far less than wild-type flies despite
having normal waking activity and circadian rhythms (Kume et al., 2005). fumin flies contain a
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defective copy of the dopamine transporter (DAT), which results in an augmentation of dopamine
signaling presumably from retention of dopamine in the synaptic cleft. A forward genetic screen
for short-sleeping mutants identified a different mutant allele of DAT, which causes a similar
phenotype to fumin (Wu et al., 2008). This finding supports shared mechanisms of sleep/wake
regulation across species, as previous studies found that DAT mutant mice experience shorter,
more fragmented sleep and increased time awake (Wisor et al., 2001). DAT is also the molecular
target of arousal-promoting drugs such as methamphetamine and cocaine (Eshleman et al.,
1994; Kilty et al., 1991). Agonists of dopamine receptors also promote wake (Monti and Monti,
2007). An increase in extracellular dopamine is associated with natural waking states in mice,
and a single population of dopaminergic neurons in the mouse ventral periaqueductal gray matter
shows increased activity during periods of wakefulness (Feenstra et al., 2000; Léna et al., 2005;
Lu et al., 2006).
Additional studies have corroborated the wake-promoting effect of dopamine signaling in
Drosophila. Drugs that increase dopamine signaling (e.g., methamphetamine and cocaine)
decrease sleep, and drugs that decrease dopamine signaling (e.g., the tyrosine hydroxylase [TH]
inhibitor 3IY) increase sleep (Andretic et al., 2005). Mutating TH in the central nervous system,
which prevents dopamine synthesis altogether, also causes a dramatic increase in sleep
(Riemensperger et al., 2011). These flies have an increased arousal threshold, which means that
they are less able to wake up in response to stimuli. This points to a role for dopamine in
promoting an awake and attentive brain state, which could be due to the general
neuromodulatory action of dopamine in increasing neuronal excitability in wake-promoting brain
regions. Reducing synaptic transmission from dopaminergic neurons reduces activity in the fly
brain in response to visual stimulation (Andretic et al., 2005), which supports a role for dopamine
in maintaining arousal and attention.
In addition to fumin, other low-sleeping mutants identified in Drosophila have been linked
to dopamine signaling. Mutations in the BTB-domain-containing protein insomniac (Inc) and its
associated E3-ubiquitin ligase Cullin-3 (Cul3) were recently both shown to decrease sleep
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(Stavropoulos & Young, 2011). Inc and Cul3 were also identified as wake-promoting
promoting genes in a
reverse genetic screen performed by Pfeiffenberger and Allada (2012)
(2012), which targeted genes with
either sleep- or wake-dependent
dependent expression or with essential roles in neuronal
nal function.
function This
study showed that normal amounts of sleep could be induced in Cul-3
3 and Inc mutants by
reducing dopamine levels with TH inhibitors 3
3-iodotyrosine and alpha-methyl-p--tyrosine.
Supporting the hypothesis of
increased dopamine signaling in
these mutants, they are resistant
to the additional wake-promoting
promoting
effects of increased dopamine
synthesis produced by L-DOPA
DOPA
feeding. However, the link to
dopaminergic signaling seems to
be non-cell-autonomous
because Inc and Cul3 are
required in
cholinergic cells, not
dopaminergic cells, for
normal sleep behavior (see Figure
1; Pfeiffenberger & Allada, 2012).
This finding underscores the
importance
of taking a circuit-wide
wide view of

Figure 1 – Dopaminergic sleep circuits
Multiple dopaminergic cell groups projecting to different
anatomical structures have been implicated in the
regulation of sleep. Individual PPL1 (red) and PPM3 (blue)
neurons projecting to the FB control baseline sleep and
isoflurane sensitivity. Dopamine receptors in the MB are
required for decreased sleep after caffeine feeding as well
as the interaction of sleep with learning and memory.
Dopamine receptors in the lLNvs
vs are sufficient to confer
normal sleep amount and may be involved in the circadian
modulation of dopamine receptor sensitivity and the
inhibition of dopaminergic arousal cues by light (yellow).
The PPL2 dopaminergic cluster (magenta) projects to the
lLNvs.

sleep regulation because many different neurons and signaling systems are likely contributing to
this complex behavior.
Effects of dopamine o
on sleep and circadian behavior are mediated in different structures
of the Drosophila brain (see Figure 1). On a molecular level, dopamine acts through specific
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receptors, which are coupled to different intracellular signaling cascades. In Drosophila, there are
two type I excitatory dopamine receptors (dDopR and dDopR2), which are coupled to Gs and
activate adenylate cyclase, and one inhibitory dopamine receptor (dD2R), which couples to Gi
and inhibits adenylate cyclase (Gotzes et al., 1994; Han et al., 1996; Hearn et al., 2002). Despite
their categorization as type I and type II, these receptors may not always conform to their
predicted excitatory or inhibitory activity. Knockdown of dD2R causes decreased locomotor
activity (Draper et al., 2007), and feeding with a dD2R-specific agonist increases locomotor
activity (Lee et al., 2013). That a receptor categorized as inhibitory promotes dopaminedependent locomotor activity is surprising; however, it is possible that dD2R acts as an excitatory
receptor in this context or that it disinhibits excitatory neurons controlling locomotion.
Although dD2R regulates locomotor activity, the sleep-relevant dopamine receptor seems
to be dDopR. Null mutation of this receptor causes increased sleep, with longer sleep bouts, in
addition to hypoactivity (Lebestky et al., 2009). It is interesting to note that dDopR mutants are
also resistant to the effects of the wake-promoting drug caffeine (Andretic et al., 2008). The
caffeine response phenotype of these mutants can be rescued by restoring dDopR to the
mushroom bodies (MBs), a region of the fly brain involved in learning and memory (see Figure 1;
Andretic et al., 2008; Kahsai & Zars, 2011). Previous studies have also demonstrated a role for
the MBs in sleep regulation; ablating the MBs in their entirety causes a sleep decrease, as does
silencing a subset of MB neurons (Pitman, 2006). However, promoting activation of a different,
non-overlapping group of neurons in the MB also causes a sleep decrease, indicating that the
MBs likely contain both sleep-promoting and wake-promoting cell groups (Joiner et al., 2006).
Determining the sleep-relevant function of dDopR in these distinct MB cell groups will help to
elucidate the processing of dopaminergic inputs to this region.
Although the MBs are involved in sleep regulation and express dopamine receptors that
may modulate the response to caffeine, dopaminergic circuits establishing baseline sleep
behavior have mapped elsewhere. The high sleep phenotype of dDopR mutants cannot be
reversed by restoring receptor expression to MBs (Lebestky et al., 2009). Two recent studies
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identified specific dopaminergic neurons, the activation of which is sufficient to induce
wakefulness (Liu et al., 2012; Ueno et al., 2012). Despite disagreement on the exact anatomical
location of the implicated cell bodies, both studies demonstrated the sufficiency of a single pair of
dopaminergic neurons to promote arousal via projections to the dorsal fan-shaped body (FB; see
Figure 1).
The FB is a sleep-promoting region that causes increased sleep when activated (Donlea
et al., 2011). Because dopaminergic neurons promote wake, it follows that they likely suppress
the activity of the FB. Indeed, the FB is responsive to sleep-suppressing dopamine signals in a
dDopR-dependent manner (Liu et al., 2012; Ueno et al., 2012). It is surprising that the
suppression of sleep-promoting signals from the FB is dependent on a type I dopamine receptor,
which is typically thought of as excitatory. It has been suggested that dDopR has an inhibitory
action in these cells in this context. However, it is also possible that the FB, like the MB, contains
sleep- and wake-promoting neurons, and the relevant dopaminergic projections synapse onto
wake-promoting cells. It is interesting to note that this dopaminergic sleep circuit is targeted by
the common volatile anesthetic isoflurane, which induces a sleep-like state. Flies with increased
dopamine signaling are resistant to isoflurane whereas flies with reduced dopamine signaling are
hypersensitive, and the ability of dopamine to suppress the activity of isoflurane activity maps to
the FB (see Figure 1; Kottler et al., 2013). It makes sense that effective and safe anesthetics
should target the brain’s natural sleep circuits to create a sleep-like unconscious state.
The high sleep phenotype of dDopR mutants is rescued by expression of dDopR in the
FB and peptidergic neurons, as demonstrated by Liu et al. (2012) and Ueno et al. (2012), but it
can apparently also be rescued by restoring dDopR expression in circadian clock neurons
(Lebestky et al., 2009). Pigment dispersing factor (PDF) is a neuropeptide expressed in the small
and large ventral lateral neurons (sLNvs and lLNvs, respectively), which are regarded as the
central clock; although of these, it is only the sLNvs that are critical for self-sustained circadian
behavior. The lLNvs are wake-promoting cells; they express dDopR and therefore may be subject
to dopaminergic modulation (Kula-Eversole et al., 2010). Indeed, GRASP analysis (green
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fluorescent protein [GFP] reconstitution across synaptic partners) has shown that projections from
the protocerebral posterior lateral 2 (PPL2) cluster of dopaminergic neurons contact clock cell
dendrites, and these connections are likely functional because lLNvs increase intracellular
calcium in response to direct dopamine application (see Figure 1; Shang et al., 2011; Wegener et
al., 2004). How the dDopR mutant phenotype can be rescued by expression in either the FB
neurons or clock cells is not clear yet; it is possible that these neurons converge on shared
downstream targets, and therefore correction of the circuit upstream can occur at one or the other
location.
Clock cell involvement in sleep and arousal circuits is important to integrate
environmental cues and cellular and molecular context to coordinate sleep and wake behavior at
appropriate times and in appropriate situations. The lLNvs promote wake in the light phase
(Parisky et al., 2008; Shang et al., 2008; Sheeba et al., 2008) whereas dopamine only promotes
wake during dark conditions (i.e., at night in cycling light/dark conditions; Kumar et al., 2012).
Light is able to suppress dopamine’s wake-promoting effects by upregulating inhibitory dopamine
receptors (dD2R) in the lLNvs (see Figure 1; Shang et al., 2011). dD2Rs are also regulated in a
circadian manner in the peripheral control of locomotion. In the peripheral nervous system and
neuromuscular junction, the sensitivity of these receptors cycles across the circadian day. The
cycling of receptor sensitivity is controlled by light-sensitive body clocks, which are entrained to
light cues by the photosensitive clock protein cryptochrome (CRY; Andretic & Hirsh, 2000). dD2R
agonist-induced hyperactivity is highest in the dark phase and low in the light phase, which is
consistent with the other studies showing that dopaminergic signaling is repressed by light. This
study is also consistent with previous findings that the dD2R paradoxically promotes hyperactivity
despite belonging to the canonically inhibitory class of type II dopamine receptors (Lee et al.,
2013).
In the absence of the circadian clock gene Clock (Clk), dopamine signaling is increased,
which results in increased arousal at night, thereby producing nocturnal behavior. The nocturnal
behavior of Clk mutants can be suppressed by silencing dopaminergic inputs to the lLNvs or by
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pharmacologically antagonizing dopamine receptors (Kumar et al., 2012). Nighttime activity in
these mutants also depends on increased expression of the circadian photoreceptor CRY in the
central clock cells in the brain, suggesting links between dopamine signaling and CRY. Daytime
light inhibits wake-promoting dopaminergic signaling, but dopamine is essential for the behavioral
response to dim light. Mutants lacking dopamine in the nervous system are defective in circadian
entrainment and phase shifts triggered by low-intensity light cues (Hirsh et al., 2010).
Dopaminergic modulation of clock cells, and possibly CRY levels, offers some insight into how it
plays a role in entrainment, but more work must be done to understand the specificity of low-light
sensitivity. In addition, understanding the role of the dopaminergic arousal cues during the
nighttime hours and determining sleep-relevant clock outputs will help us understand the plastic
and interconnected circuits that allow for normal cycles of sleep/wake behavior in wild-type flies.
This multiplicity of wake-promoting signals to the clock that can trigger suppression of other
signals is an excellent example of how sleep circuits can receive and prioritize multiple contextual
inputs to result in the most advantageous behavior in a particular situation.
In summary, dopaminergic cell groups project to different anatomical regions of the
Drosophila brain to modulate arousal in response to various cues. Having several parallel
neuromodulatory circuits that each communicates different aspects of environmental and
physiological context to sleep centers in the brain provides flexibility in adapting behavior to a
changing environment. The ability to prioritize conflicting environmental cues by strengthening
one circuit and suppressing others may be an evolutionary advantage to having multiple sites of
neuromodulatory input.

Octopamine
Octopamine in invertebrates is an analog of adrenergic neurotransmitters in vertebrates.
It acts similarly to epinephrine and norepinephrine and controls some of the same behaviors,
including memory formation and aggression (Roeder, 2005; Sara, 2009; Yanowitch & Coccaro,
2011). Norepinephrine has been shown to regulate mammalian sleep (Aston-Jones & Bloom,
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1981), and we now know that octopamine regulates sleep in Drosophila. Decreasing octopamine
levels by mutating biosynthetic enzymes causes an increase in total sleep amount as well as
changes in other indicators of increased sleep drive such as increased arousal threshold and
decreased latency to sleep (Crocker & Sehgal, 2008). These phenotypes can be rescued by
pharmacologic administration of octopamine. Electrically exciting or silencing octopaminergic
neurons causes decreased or increased sleep, respectively. Ectopically expressing a sodium
channel to excite only the anterior superior medial (ASM) cluster of octopaminergic neurons
decreases sleep, identifying these as the sleep-relevant octopaminergic cells (Crocker et al.,
2010). The adrenergic antagonist mianserin blocks the wake-promoting effect of octopamine,
underscoring that these systems are homologous (Crocker & Sehgal, 2008).
The sleep-promoting effect of octopamine requires protein kinase A (PKA) signaling
(Crocker & Sehgal, 2008). It is interesting to note that PKA is a signaling molecule already known
to play a role in sleep regulation, especially in the MBs (Joiner et al., 2006). In mapping the sleeprelevant neuronal targets of octopamine signaling, Crocker et al. (2010) discovered that inhibiting
PKA in the pars intercerebralis (PI)—not in the MBs—was able to block the wake-promoting
effects of octopamine (see Figure 2). The PI is thought to be the Drosophila equivalent of the
hypothalamus based on similarities of development and function, as well as expression of similar
neuropeptides (de Velasco et al., 2007). It consists of a collection of neurosecretory cells in the
far dorsomedial area of the brain with pronounced ventral projections. These cells express
multiple octopamine receptors, one of which, octopamine receptor in the mushroom body
(OAMB), is required for octopaminergic control of sleep.
The PI cells downstream of octopamine in the sleep circuit are marked by Dilp2-Gal4,
which is expressed in insulin-producing cells. Despite insulin production being the major function
of these cells, this does not seem to be the mechanism by which octopamine modulates sleep.
Increasing or decreasing insulin signaling does not itself alter sleep behavior. On the other hand,
increasing octopamine signaling does increase triglycerides—a measure of metabolism and
energy storage—and this connection is mediated by insulin signaling. Although the control by
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octopamine of sleep and metabolism seems to be unrelated, it is true that metabolic state can
affect sleep behavior. For example, in periods of starvation, flies with low octopamine signaling
will overcome
rcome their sleep drive
to forage, and flies with high
octopamine signaling will not
increase foraging activity
despite being more generally
active. This is likely because
flies with low octopamine have
low energy stores and cannot
withstand lack of food supply
whereas
those with high
octopamine have nutrient
reserves and therefore have
less need to forage (Erion et al.,
2012).
Thus, in either
scenario, metabolic needs
dominate over sleep need. The
mechanism by which
octopamine modulates baseline

Figure 2 – Serotonergic, histaminergic, and
octopaminergic sleep circuits
Serotonergic cells (blue) project to many brain regions,
including the MB, where they promote sleep through the d5d5
HT1A receptor. They project to the PI, where they promote
sleep and feeding. They also project to the ellipsoid body,
where they may participate
ate in some elements of circadiancircadian
dependent behavior through the d5-HT2
HT2 receptor. The 5HT5HT
1B receptor inhibits sensitivity to light-induced
induced phase shifts
and may act through the LNvs to mediate this aspect of
circadian entrainment. Octopaminergic neurons (magenta),
(m
specifically the ASM cluster, promote wake via their
projections to the PI. They also signal to the lLNvs, which
respond to octopamine specifically during the night phase of
the circadian day. In addition, histaminergic neurons (red)
seem to promote
te wakefulness via HisCl1 receptors in the
PDF clock neurons.

sleep behavior through the PI is still unknown, but the interplay and prioritization of arousal and
metabolic signals through this brain region is another example of how numerous inputs can allow
for behavioral
ral plasticity on the basis of context.
Octopamine not only modulates sleep through the PI, but it may also communicate wakewake
promoting signals to the lLNvs, as does dopamine (see Figure 2). The lLNvs express octopamine
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receptors and respond to octopamine application by increasing cyclic adenosine monophosphate
(cAMP). The sensitivity of clock cells to octopamine is dependent on time of day: In light/dark
conditions, lLNvs respond to octopamine in the dark phase, and in constant dark conditions
octopamine sensitivity is high only during the subjective night. In addition, when the clock gene
period (per) is mutated, octopamine sensitivity of the clock neurons decreases significantly
(Shang et al., 2011). Therefore, the wake-promoting effects of octopamine are dependent on
circadian and metabolic cues and may depend on other endogenous or environmental conditions.
Octopaminergic cells also project to other brain loci previously reported to be involved in sleep
regulation, such as the FB and the MBs; however, it is currently unknown whether these inputs
can modulate sleep in different contexts (Busch et al., 2009).
Serotonin
Similar to dopamine and octopamine, serotonin is involved in modulating many
behaviors, including learning, mating, and aggression, and it has been implicated in sleep and
circadian behaviors (Becnel et al., 2011; Dierick & Greenspan, 2007; Sitaraman et al., 2008). In
2006, Yuan and colleagues tested for sleep phenotype in mutants of three different serotonin
receptors and discovered that receptor d5-HT1A promotes sleep. Flies expressing a mutated
form of the receptor showed reduced and fragmented sleep. In addition, these flies were unable
to get wild-type levels of rebound sleep after a period of sleep deprivation. Pharmacological and
genetic augmentation of serotonin production increases sleep, confirming that serotonin is sleeppromoting (Yuan, Joiner, & Sehgal, 2006).
Serotonergic neurons project to multiple brain regions that have been previously
identified as part of sleep-regulatory circuitry, including the PI and the MB (Lee et al., 2011; Luo
et al., 2012; Pech et al., 2013). In the d5-HT1A mutant flies, wild-type sleep levels can be
restored by expressing d5-HT1A only in the MB, indicating that this is the structure that receives
sleep-relevant serotonergic inputs (see Figure 2; Yuan et al., 2006). On the other hand, serotonin
signaling to the PI seems to modulate feeding and metabolism (Luo et al., 2012).
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In addition to regulating baseline sleep levels and homeostatic response to sleep
deprivation, serotonin is also involved in modulating circadian control of sleep and activity. The
serotonin receptor d5-HT2, which is expressed in the protocerebrum and ellipsoid body, may
modulate circadian behavior. Flies fed a d5-HT2 agonist display increased activity in the early
daytime and lose the anticipatory behavior that precedes light/dark transitions (Nichols, 2007).
This anticipatory behavior is a typical sign of circadian clock entrainment, and loss of anticipation
can indicate reduced rhythmicity or impaired entrainment. Increasing serotonin signaling in flies,
either by feeding serotonin or serotonin reuptake inhibitors, decreases their sensitivity to lightinduced phase shifts, which is another indicator of weakened circadian entrainment. This effect
on phase shift sensitivity seems to act through the d5-HT1B receptor because overexpressing or
knocking down this receptor decreases or increases circadian sensitivity to light pulses,
respectively. d5-HT1B is expressed in clock cells in the brain, where it likely acts to modulate
circadian entrainment (see Figure 2; Yuan et al., 2005). However, it is also expressed in the MBs
and PI, where it could potentially modulate the sleep circuit on the basis of light and circadian
cues.
Histamine
Histamine is a monoamine neurotransmitter with a well-established role in Drosophila
photoreception and temperature sensing (Hong et al., 2006; Witte et al., 2002). However, until
very recently, it was only known to regulate sleep and wake in mammalian systems (Parmentier
et al., 2002). A wake-promoting role for histamine has now been demonstrated in Drosophila by
knocking down histamine biosynthetic pathways and demonstrating an increase in sleep (Oh et
al., 2013). In addition, mutation of a single histamine receptor, HisCl1, causes a similar increase
in sleep. It is interesting to note that this histaminergic sleep regulation maps to the clock neurons
+

because expression of HisCl1 in PDF cells is necessary and sufficient for normal sleep behavior
(see Figure 2; Oh et al., 2013). An earlier anatomical study identified histaminergic projections
from extraocular eyelet photoreceptors to the ventral lateral neurons, which could be the wakepromoting histaminergic circuit (Hamasaka & Nässel, 2006). Thus, histaminergic
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neuromodulation may provide a novel mechanism for communicating light cues from the visual
system to the central clock for regulation of behavior. The ability of the circadian clock to drive
robust rhythmic locomotor behavior, even in the absence of light cues, would seem to preclude
the necessity for this type of neuromodulatory input. However, it is possible that the wakepromoting cues from the lLNvs (as opposed to the circadian cues from the sLNvs) are more
plastic and responsive to slight modulation. More research must be done to establish the role for
histamine in controlling sleep/wake behavior and the type of environmental information it may be
conveying.
Each of the major monoamine neurotransmitters discussed regulates broad and
overlapping lists of complex behaviors, including sleep. Sleep regulation has been attributed to
many different signaling pathways, brain structures, and circuits, but we still lack a cohesive
understanding of how this essential behavior is established. We undertook a small molecule
screen to determine whether modulating behavior specifically in adulthood would uncover new
information that has been missed in genetic screens. Further work investigating two drugs from
this screen found that both affect sleep/wake balance by presynaptically modulating monoamine
signaling. This body of work underscores the power of pharmacological screens and utilizes a
sleep-promoting and a wake-promoting drug to uncover novel presynaptic controls of sleep
behavior.

13

CHAPTER 1 – Small-molecule screen in adult Drosophila
identifies VMAT as a regulator of sleep
Published: Nall A and Sehgal A. (2013) Small-molecule screen in adult Drosophila identifies
VMAT as a regulator of sleep. J Neurosci, 33(19):8534-40.

ABSTRACT
Sleep is an important physiological state, but its function and regulation remain elusive. In
Drosophila melanogaster, a useful model organism for studying sleep, forward genetic screens
have identified important sleep-modulating genes and pathways; however, the results of such
screens may be limited by developmental abnormalities or lethality associated with mutation of
certain genes. To circumvent these limitations, we used a small-molecule screen to identify sleepmodulating genes and pathways. We administered 1280 pharmacologically active small
molecules to adult flies and monitored their sleep. We found that administration of reserpine, a
small molecule inhibitor of the vesicular monoamine transporter (VMAT) that repackages
monoamines into presynaptic vesicles, resulted in an increase in sleep. Supporting the idea that
VMAT is the sleep-relevant target of reserpine, we found that VMAT-null mutants have an
increased sleep phenotype, as well as an increased arousal threshold and resistance to the
effects of reserpine. However, although the VMAT mutants are consistently resistant to reserpine,
other aspects of their sleep phenotype are dependent on genetic background.
These findings indicate that small-molecule screens can be used effectively to identify
sleep-modulating genes whose phenotypes may be suppressed in traditional genetic screens.
Mutations affecting single monoamine pathways did not affect reserpine sensitivity, suggesting
that effects of VMAT/reserpine on sleep are mediated by multiple monoamines. Overall, we
identify VMAT as an important regulator of sleep in Drosophila and demonstrate that smallmolecule screens provide an effective approach to identify genes and pathways that impact adult
Drosophila behavior.
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INTRODUCTION

Sleep is an important physiological state, as evidenced by the fact that we spend a third
of our lives in this state. Additionally, sleep deprivation causes cognitive and health deficits,
indicating that it plays an essential role in physiological homeostasis. Sleep is not just required in
humans; all well-studied animals exhibit sleeplike states. Among these animals are common
model organisms, including mice, zebrafish, flies, and nematode worms (Allada and Siegel, 2008;
Mackiewicz et al., 2008; Raizen et al., 2008; Bushey and Cirelli, 2011). These models and others
are being used to investigate outstanding questions regarding the purpose of sleep and its
regulation.
The rest state in the fly shares many commonalities with human sleep behavior (Shaw et
al., 2000, Hendricks et al., 2000). For example, sleeping flies stop moving and assume a
stereotyped posture. They also exhibit an increased arousal threshold, meaning that they require
a stronger stimulus to reinitiate activity. Importantly, flies display a homeostatic need for sleep,
such that they compensate for periods of sleep deprivation with subsequent rebound. Drosophila
melanogaster follow a diurnal pattern, resting mostly during the night and taking a mid-afternoon
“siesta.”
The simplicity of behavioral assays using Drosophila, combined with the ease of genetic
screens, has led many researchers to turn to this model to elucidate the genetic and molecular
mechanisms underlying sleep regulation. Genetic screens have uncovered a few low-sleeping
mutants, but these studies have not yet led to a cohesive account of sleep regulation. Given that
sleep appears to be an essential process (Rechtschaffen et al., 1983; Shaw et al., 2009), it is
likely that many sleep-regulating genes are also essential. In other words, loss of these genes
may cause lethality or gross developmental problems, precluding their detection in traditional
genetic screens. To complement previous genetic screens and to find novel sleep-regulatory
molecules and pathways, we conducted a small-molecule screen for sleep phenotypes in adult
Drosophila. Here, we report the findings from this screen, which indicate a strong effect of
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monoaminergic neurotransmission in regulating sleep quantity. Using both pharmacological and
genetic approaches, we investigated the role of one of our hits in regulating sleep behavior.

MATERIALS AND METHODS
Flies
Wild-type iso31 flies (Ryder et al., 2004) were used for drug screen and subsequent experiments.
VMAT

p1

mutants were a kind gift of the Krantz laboratory (University of California–Los Angeles,

Los Angeles). TrH

co1440

(BSC10531), Hdc

MB07212

(BSC25260) mutants were ordered from the
f00602

Bloomington Stock Center (Bloomington, Indiana), and Gad1

was ordered from the Exelixis
ts

collection at Harvard Medical School. The temperature-sensitive tyrosine hydroxylase mutant ple
(Pendleton et al., 2002) was a kind gift from Dr. Ralph Hillman (New York University, New York).
The octopamine synthesis mutant TbH

nm18

was previously published (Crocker and Sehgal, 2008).

Drug feeding
We used the LOPAC 1280 drug library (Sigma-Aldrich), which is made up of bioactive molecules
with known molecular targets, of which approximately half are involved in neurotransmission.
Four- to 6-day-old adult isogenic (iso31) flies were given access to drugs at 20 µM, mixed into
their 2% agar and 5% sucrose food, ad libitum for 1 week. Flies were kept in incubators at 25°C
on a 12 h light/dark schedule. During this time, locomotor activity of flies was monitored using the
Drosophila Activity Monitoring System (Trikinetics). Sleep behavior was calculated and averaged
for four male flies and four female flies per drug treatment. Sleep graphs and calculations of sleep
quantity for all experiments were generated using PySolo (Gilestro and Cirelli, 2009). For drugs
that produced qualitative changes in sleep profile or quantitative changes in total minutes of sleep
per day, four male and four female flies were tested again at 50 µM drug. Drugs that showed a
reproducible, dose-dependent effect on sleep quantity were considered screen hits. For reserpine
(Sigma-Aldrich), the stock solution was made at 10 mM in DMSO. This stock solution was diluted
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in 2% agar/5% sucrose food to final concentrations of 20 and 50 µM for the original screen and
10 µM for all subsequent experiments. A total of 0.2% DMSO vehicle controls were used as a
comparison for 20 µM drug feeding during the screen, and 0.1% DMSO vehicle controls were
ts

used as a comparison for 10 µM reserpine feeding in subsequent experiments. For the ple

mutants, flies were kept at a restrictive temperature of 29°C for 24 h before placing on DMSO and
reserpine and were kept at this temperature for the duration of behavioral monitoring.

Arousal threshold
Arousal threshold assay was conducted as previously published (Wu et al., 2008). Mechanical
stimuli were applied manually by tapping a dowel on the behavior tubes containing the flies.
Weak (one light tap), medium (one strong tap), and strong (six strong taps) stimuli were applied
to behavior tubes at ZT16, ZT18, and ZT20, respectively. The percentage of spontaneously
sleeping flies awoken was calculated for each genotype and stimulus.

Sleep deprivation
Flies were deprived during the final 6 h of the night (ZT18-ZT24) using a vortex to shake flies for
2 s of every 20 s, at random intervals (Huber et al., 2004). Amount of sleep lost was calculated by
subtracting minutes of sleep during deprivation from the minutes of sleep during the same interval
on the previous night. Sleep regained the following morning was calculated by subtracting the
minutes of sleep during the first 3, 6, or 12 h the morning before deprivation from the same
interval after deprivation.

PCR
The wild-type vesicular monoamine transporter (VMAT) allele was genotyped using VMATp1-F
(5’-ATC GGG GGA TGC TTG ATA TT-3’) and VMATp1-R (5’-ATC CGA ATC GGG AAC AGA T3’) primers, and the mutant VMAT

p1

allele was genotyped using the Plac1 (5’- CAC CCA AGG

CTC TGC TCC CAC AA-3’) primer and VMATp1-R primers. PCR was conducted with GoTaq
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Flexi (Promega), with the following cycling conditions: 95°C for 2 min, then 30 cycles of 95°C for
30 s, 52°C for 1 min, 72°C for 1 min, and final ext ension at 72°C for 5 min.

Sleep latency
Latency to sleep was calculated by counting the number of minutes between lights off and the
first stretch of 5 consecutive minutes with zero beam crosses, as recorded by the Drosophila
Activity Monitoring System.

RESULTS
A small-molecule screen identifies sleep-modulating compounds
We screened 1280 small molecules for their effect on sleep:wake rhythms in the adult fly
(Fig. 1.1). Observation of daily locomotor behavior allowed for quantitative comparisons of total
sleep time, daytime and nighttime sleep, and qualitative assessment of sleep patterns, rhythm
strength, and anticipation of light/dark transitions. Each drug was assayed in a limited number of
flies to enhance throughput; therefore, only drugs with strong effects on sleep were identified as
having an effect above individual variation. Additionally, all compounds were fed to flies at a
relatively low dose that caused minimal lethality. Many of these drugs showed an effect in only
one sex and were discarded from further testing. Even with these constraints, we were able to
identify 38 compounds that affected sleep at the initial concentration. Only those drugs found to
have a dose-dependent effect on sleep in both sexes when tested at a higher concentration were
considered hits. With these stringent criteria, we initially found six compounds that qualified: five
that decreased sleep and one that increased sleep. One of the sleep-reducing compounds, the
cholinergic agonist carbachol, did not continue to have an effect in subsequent studies (data not
shown). The four remaining sleep-reducing drugs caused a significant reproducible decrease in
nighttime sleep at a 20 µM concentration and a further reduction in sleep levels at 50 µM. These
sleep-promoting drugs are pergolide methanesulfonate (Fig. 1.2a), R(-)-2,10,11-
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trihydroxyaporphine hydrobromide (Fig. 1.2b), paliperidone (Fig. 1.2c), and 1,3-dipropyl-7methylxanthine (Fig. 1.2d). The screen revealed a single sleep-promoting drug, reserpine (Fig.
1.2e). Reserpine caused a significant increase in sleep during both the day and night, especially
at light/dark transitions when flies are most active (p=0.000161 by one-way ANOVA with Tukey
post hoc comparison for both the 20 µM and 50 µM reserpine-fed flies compared with DMSO
controls). In female flies, sleep increased by 400 min at 20 µM reserpine and by 470 min at 50
µM reserpine (Fig. 1.3a). Male flies showed a similar behavioral response to drug treatment.

Figure 1.1 – Schematic of the small molecule screen
4 male and 4 female flies were screened for each of 1,280 known bioactive drugs. At 4-6 days
post eclosion, adult flies were put in tubes with food containing 20µM of drug. These tubes
were placed in monitors, and locomotor activity was measured for 5 days using the Drosophila
Activity Monitoring (DAM) System. Using pySolo, sleep profiles were generated for males and
females for each drug and compared to flies fed 0.01% DMSO (control). If a drug altered
sleep in both males and females, it was re-tested at 50µM. If the drug had a dose-dependent
effect, it was considered a positive hit.
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Figure 1.2 - Small molecule
screen identifies sleepsleep
modulating compounds
Sleep profiles for female flies fed
0.1% DMSO (black line), 20µM
20
drug (blue line), and 50µM
50
drug
(green line) for each of the positive
hits from the screen: pergolide
methanesulfonate (a), R(-)R(
2,10,11-trihydroxyaporphine
trihydroxyaporphine
hydrobromide (b), paliperidone (c),
1,3-dipropyl-7-methylxanthine
methylxanthine (d),
and reserpine (e). Sleep is plotted
as minutes of sleep per sliding 30
minute window across a 24 hour
period (12 hours light (white bar)
and 12 hours dark (black bar) with
averaged data from 4 female flies
over 5 days of recording.

Genetic ablation of VMAT alters
sleep behavior
Reserpine is an inhibitor of
the VMAT. To determine whether the
effects of reserpine on sleep were
mediated by its inhibition of VMAT,
we compared the sleep phenotype of reserpine
reserpine-treated
treated flies with that of a VMAT-null
VMAT
mutant,
VMAT

p1

(Simon et al., 2009). The VMATp1 homozygous mutant has the same significantly
p1

p1

increased sleep quantity as flies fed 50 µM reserpine (p=0.000144 forVMAT /VMAT compared
with iso31 as shown by one
one-way ANOVA with Tukey post hoc comparison) (Fig. 1.3a).
Importantly,
rtantly, inhibition of VMAT by drug treatment or genetic mutation does not render flies
hypoactive, as measured by activity index (activity per waking minute) (Fig. 1.3b
b), indicating that
the effect is specific for sleep.
We next asked whether inhibition o
off VMAT causes increased sleep depth in addition to
increased sleep quantity. To assess sleep depth, we measured arousal threshold, in other words,
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the ability of the animal to wake up with sensory stimulation. We delivered weak, medium, and
strong stimuli to flies at different times of the night and counted the number aroused in different fly
lines. We found that a smaller percentage of the drug
drug-treated iso31 and the VMAT

p1

homozygous

mutants awaken in response to these mechanical stimuli, compared with unt
untreated
reated iso31 flies
(Fig. 1.3c).
). The contribution of genotype to arousability at all stimulus intensities was significant
(p<0.0001 by two-way
way ANOVA).

Figure 1.3 – Genetic ablation of VMAT Alters Sleep Behavior
(a) Total minutes of sleep per 24
24-hour day plotted for wild type (iso31) flies fed 0.1% DMSO
(vehicle control), 20µM
M reserpine, and 50
50µM
M reserpine, as well as for iso31, VMATp1/iso31
and VMATp1/VMATp1 fed sucrose/agar food. n=8 for each genotype/treatment; *** indicates
p<0.001. (b) Activity index
ex (infrared beam crosses per waking minute) for these reserpinereserpine
treated and VMATp1 mutant flies shows these flies are not hypoactive. (c) The percent of
sleeping flies that were aroused from sleep by a weak (white bars), medium (gray bars), or
strong (black
lack bars) stimulus at ZT16, ZT18, or ZT20, respectively. Data are averaged from
three separate experiments; **** indicates p<0.0001 for the effect of treatment/genotype on
arousability. (d) Flies were deprived of sleep during the second half of the night (ZT18-ZT24).
Minutes of sleep lost during this period (white bar) are plotted as a negative number, and
rebound sleep was measured during the first 3 (light gray bar), 6 (gray bar), and 12 hours
(black bar) the following morning. ** indicates p<0.01 and *** indicates p<0.001 for the
amount of sleep lost compared to iso31 controls, n=16 for each genotype/treatment.
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We also measured the effect of VMAT inhibition on the homeostatic rebound that follows
a period of sleep deprivation. We deprived flies of sleep during the second half of the night and
assayed rebound sleep the following morning. Drug-treated and homozygous mutant flies were
less effectively deprived than wild type and heterozygous flies (p=0.00322 and p=0.000185 for
p1

iso31 vs. VMAT / VMAT

p1

and reserpine-treated flies, respectively, by one-way ANOVA with

Tukey’s post hoc), further supporting the idea that sleep depth is increased by inhibition of VMAT.
Mutant and drug-treated flies experienced slightly less rebound sleep as well, although this
difference did not reach significance because of large inter-individual variance (Fig. 1.3d). The
apparent reduction in sleep rebound by these flies is likely the result of the relatively ineffective
deprivation and already elevated baseline sleep levels.

Effects of reserpine on sleep map to the VMAT gene
p1

In VMAT flies, the VMAT gene is disrupted by insertion of a PLacW transposon in the
fifth exon of the VMAT gene (Bellen et al., 2011). To confirm the presence of this transposon, we
genotyped VMAT

p1

flies by PCR. The wild-type VMAT allele, detected using primers specific for

the VMAT genomic sequence, was amplified from iso31 flies and from flies heterozygous for the
mutation, but not from homozygous mutants. Heterozygous and homozygous mutants were
positive for the mutant VMAT allele, which was detected using one VMAT primer and one
transposon-specific primer (Fig. 1.4a,b).
If effects of reserpine on sleep are mediated through inhibition of VMAT, then VMAT
mutants should be resistant to reserpine. Indeed, theVMAT

p1

mutant does not show a further

sleep increase after reserpine administration (Fig. 1.4c). Additionally, reserpine resistance of
theVMAT

p1

mutant was not complemented by the deficiency Df(2R)BSC306, which spans the
p1

VMAT locus (Fig. 1.4c). The fact that the VMAT /Df(2R)BSC306 flies had a phenotype
comparable to homozygous mutants indicates the mutation is likely null. Together, these data
indicate that VMAT mutants are resistant to reserpine, and the effect maps to the VMAT locus.
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The sleep phenotype of VMAT mutants is background dependent
p1

To determine whether the sleep phenotype of the
theVMAT mutation is independent of
genetic background, we outcrossed the mutation for five generations into an iso31 background.
The presence of the transposon was confirmed by PCR (Fig. 1.4b).
). Surprisingly, outcrossed
outcr
p1

VMAT mutant flies (VMAT (5x) flies) slept for approximately the same number of minutes per
p1

day as the iso31 control flies (846 min/d for iso31 females vs. 881 min/d for VMAT (5x)/
p1

VMAT (5x); Fig. 1.5a,b).
). Despite the largely normal baseline sleep behavior, however, the
p1

VMAT (5x)) flies consistently exhibited decreased sleep latency, which means that they fell
asleep more quickly than wild
wild-type or heterozygous flies after lights out (p=0.035
0.035 by unpaired t
test with Welch’s correction for unequal var
variances; Fig. 1.5c).
). Additionally, these mutant flies
retained an increased arousal
threshold after outcrossing (Fig.
1.5d),
), similar to the original

Figure 1.4 – Effects of
reserpine on sleep map to the
VMAT Gene
(a) The VMAT gene, with dark
gray boxes representing exons,
showing locations of PCR
primers used to genotype the
wild type VMAT (top) and Pelement-containing
containing mutant
VMATp1 (bottom) alleles. (b)
PCR amplifies the wild type
VMAT allele (top) in iso31 and
VMATp1/iso31 heterozygous
flies and the VMATp1 mutant
allele (bottom) in heterozygous
and homozygous VMATp1
mutant flies. (c) Total minutes
min
of sleep per 24-hour-day
24
for
wild type, heterozygous mutant,
homozygous mutant, and
mutant/deficiency transtrans
heterozygotes fed 0.1% DMSO
(white bars) or 10µM
10
reserpine
(black bars). *** indicates
p<0.001, n=16 for each
genotype/treatment.
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mutant strain (p=0.0100
0.0100 by two
two-way ANOVA for genotype contribution to arousability). Like the
p1

original mutant, the VMAT (5x)mutants were less efficiently sleep-deprived (p=
=0.0003 by oneway ANOVA) but showed a rebound the following morning proportional to sleep lost during
deprivation (Fig. 1.5e).

Figure 1.5 - The sleep phenotype of VMAT mutants is background dependent
(a) Sleep profile for iso31 (black line), VMATp1(5x)/iso31, and VMATp1(5x)/VMATp1(5x)
outcrossed mutant flies. Sleep is plotted as minutes of sleep per sliding 30 minute window
across a 24 hour
our period (12 hours light (white bar) and 12 hours dark (black bar) with
averaged data from 16 female flies over 5 days of recording. (b) Total sleep per 24 hour period
quantified for these flies fed 0.1% DMSO (white bars) or 10
10µM
M reserpine (black bars). ***
indicates p<0.001. (c) Scatter plot of latency to sleep, or minutes between lights off and the
first sleep bout. Horizontal line corresponds to group mean. * indicates p<0.05. (d) The
percent of sleeping flies that were aroused from sleep by a weak (white bars), medium (gray
bars), or strong (black bars) stimulus at ZT16, ZT18, or ZT20, respectively. Data are averaged
from three independent experiments; * indicates p<0.05 for the effect of genotype on
arousability. (e) Flies were deprived of sleep d
during
uring the second half of the night (ZT18-ZT24).
(ZT18
Minutes of sleep lost during this period (white bar) are plotted as negative numbers, and
rebound sleep was measured during the first 3 (light gray bar), 6 (gray bar), and 12 hours
(black bar) the following morning. *** indicates p<0.001 for the amount of sleep lost compared
to iso31 controls, n=16 for each genotype.
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p1

Importantly, VMAT (5x) mutants were still resistant to the sleep-promoting
promoting effects of
reserpine (Fig. 1.5b).
). Because these mutants have normall baseline sleep, the lack of a response
to reserpine cannot be the result of a ceiling effect. These data establish that VMAT is required
for effects of reserpine on sleep.

Effects of reserpine on mutants of different monoaminergic systems
VMAT is a transporter protein that packages all monoaminergic neurotransmitters into
presynaptic vesicles.
les. To determine which of the monoamines is responsible for the sleep
phenotype produced by reserpine, we fed reserpine to mutants deficient for the various
ts

c01440

monoamines. Mutants deficient in the synthesis of dopamine (ple ), serotonin (TrH
TrH
octopamine (TbH

nm18

f00602

GABA (Gad1

B07212

), histamine ((HdcM

),

), and the amino acid-derived neurotransmitter

) all responded to reserpine (Fig. 1.6).
6). Because dopamine synthesis is required
ts

during development, the only viable mutant ((ple ) is temperature-sensitive, and so the drug
treatment and sleep behavior for this mutant were measured at the restrictive temperature of
29°C. Reserpine increased sleep significantly for all of the neurotransmitter mutants (comparing
total sleep of DMSO controls with 10 µM reserpine-treated
treated flies of the following genotypes,
ts

p=0.000139 for iso31, p=0.00355
0.00355 ple at 29°C, p=0.000144 for TrH
TbH

nm18

, p=0.000137 for Hdc

MB07212

f00602

, and p=0.000151 for Gad1

co1440

, p=0.000137
0.000137 for

by two-way ANOVA with

Bonferroni multiple compari
comparisons),
sons), indicating that no single neurotransmitter system is required for
sleep-promoting
promoting effects of reserpine. VMAT inhibition likely increases sleep by interfering with the
signaling from more than one neurotransmitter system simultaneously.
Figure 1.6 - Effects of reserpine on
mutants
of different monoaminergic systems
Total sleep per 24 hour period plotted for
mutants defective in the synthesis of the
neurotransmitters dopamine (plets at 29oC),
serotonin (TrHco1440), octopamine
(TbHnm18), histamine
istamine (HdcMB07212), and
GABA (Gad1f00602), fed 0.1% DMSO (white
bars) or 10µM
M reserpine (black bars). **
indicates p<0.01 and *** indicates p<0.001.
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DISCUSSION
Genetic screens for sleep phenotypes have led to the isolation of a few mutants,
including Shaker (Cirelli et al., 2005), sleepless (Koh et al., 2008), insomniac (Stavropoulos and
Young, 2011), and cyclinA1 (Rogulja and Young, 2012). Other mutations that cause reduced
sleep were identified by chance, including fumin (Kume et al., 2005) and several mutations in the
calcineurin signaling pathway (Nakai et al., 2011), or through assays of candidate genes (Yuan et
al., 2006; Crocker and Sehgal, 2008, 2010; Sehgal and Mignot, 2011). Although these studies
give valuable insight into molecular underpinnings of sleep behavior, they do not paint a complete
picture of the molecular machinery of sleep regulation.
We note that traditional genetic screens may be limited in their ability to uncover
molecules that regulate behavior because of factors, such as redundancy, lethality,
developmental compensation, and developmental defects, which may mask or conflate adult
phenotypes. The study of sleep is particularly susceptible to these limitations, as long-term sleep
deprivation leads to death (Rechtschaffen et al., 1983; Shaw et al., 2009). In addition, sleepregulating genes tend to also be required for other functions. One way to bypass the limitations
intrinsic to traditional genetic screens is to use adult-specific manipulations. We asked whether
we could use a small-molecule screen to discover new sleep-modulating proteins.
Small-molecule screens in whole animals are rare, especially when measuring a
behavioral output. A small-molecule screen for aberrant sleep behavior in zebrafish assayed
larvae, through automated methods, for effects of almost 4000 drugs (Rihel et al., 2010).
Conducting a drug screen in Drosophila, although more labor-intensive, was important to find new
sleep-modulating molecular targets in a well-established sleep model. Additionally, an enormous
genetic toolkit is available in Drosophila for confirming and elaborating on drug screen findings.
In the screen reported here, we searched for drugs that dose-dependently and
reproducibly affected sleep behavior in both male and female adult flies. Two of the compounds
that met these strict criteria are dopamine receptor agonists. Other drugs that increase dopamine
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signaling, such as methamphetamine and cocaine, are known to increase arousal in humans and
model organisms, including Drosophila. Inhibition of dopamine biosynthesis biochemically
(Andretic et al., 2005) and genetically (Riemensperger et al., 2011) has the opposite effect,
increasing sleep amount in the fly. Also, the dopamine type 1 receptor, dDopR, promotes arousal
at appropriate times in the circadian sleep/wake cycle (Lebestky et al., 2009). The identification of
small molecules targeting dopaminergic signaling validates the power of the drug screen to
identify sleep-regulatory pathways.
Another sleep-inhibiting molecule identified in the screen was methylxanthine, which is a
caffeine analog. Caffeine is well known as a robust wake-promoting stimulant. Although the target
of its action in Drosophila is still unclear, its effects on behavior are similar to those in
mammals/humans (Wu et al., 2008). As in the case of the molecules that affect dopaminergic
signaling, the identification of a caffeine analog speaks to the efficacy of the small-molecule
screen reported here. This screen also identified an atypical antipsychotic, paliperidone, as a
sleep-inhibiting molecule. The target of this antipsychotic is not known, but its effect on sleep
supports reports of links between sleep and affective disorders (Wulff et al., 2010).
Surprisingly, only one drug from the screen was found to increase sleep: reserpine.
Although reserpine, which is typically used to treat hypertension and is also indicated as an
antipsychotic, was shown many years ago to have a tranquilizing effect, it has not been
mechanistically linked to sleep (Monroe et al., 1955; Steiner et al., 1963). We now have the
genetic tools to understand the nature of this effect in a controlled and systematic manner and its
implications for the normal regulation of sleep and wake. Reserpine inhibits the function of the
VMAT, a transmembrane protein that transports monoaminergic neurotransmitters into
presynaptic vesicles to prepare them for release. Vertebrates have two VMAT genes, VMAT1 and
VMAT2, whereas flies have only one.
One common caveat in pharmacological studies is the possibility of off-target effects. We
show that a VMAT

p1

null mutant (Simon et al., 2009) has increased sleep. More importantly, this

mutant is resistant to the effects of reserpine, indicating that the long-sleeping phenotype is not
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the result of off-target effects. An apparent increase in sleep can sometimes result from sickness
or physical impairment. However, despite sleeping significantly more, the reserpine-fed and
VMAT

p1

mutant flies do not have a decreased activity index. In addition, outcrossed VMAT

mutants, which have normal levels of baseline sleep, are unresponsive to reserpine. Together,
these data show that reserpine specifically increases sleep by inhibiting VMAT.
Alterations in sleep duration are often accompanied by changes in sleep depth, as
measured by arousal threshold. Previous studies have shown that short-sleeping mutants tend to
have decreased arousal thresholds during normal sleep (Koh et al., 2008). Interestingly, the longsleeping VMAT

p1

mutant has an increased arousal threshold, suggesting that they sleep more

deeply (Andretic and Shaw, 2005). In general, loss of VMAT appears to increase sleep drive or
decrease the ability to maintain wakefulness, as demonstrated also by the increased latency to
sleep in flies carrying a five-generation outcrossed VMAT

p1

allele. These outcrossed flies no

longer have increased daily sleep, but they also display an increased arousal threshold. On the
other hand, VMAT

p1

flies have a normal rebound after deprivation, supporting the idea that the

response to sleep deprivation is less tightly correlated with other measures of sleep.
The less severe phenotype of the outcrossed allele is consistent with other studies that
have noted the importance of genetic background in animal behaviors, including sleep
(Zimmerman et al., 2012). In an iso31 background, inhibition of VMAT throughout development
with the VMAT

p1

mutation does not alter daily sleep, but sleep is increased sleep when VMAT is

inhibited acutely in adults. Thus, developmental compensation mechanisms may account for the
discrepancy between the sleep phenotype of the drug-fed and mutant flies in the iso31 genetic
background. The original mutant background likely confers less developmental compensation, as
these flies have the same long-sleeping phenotype as the drug-fed flies.
VMAT plays a presynaptic role in signaling by many different neurotransmitters, including
the monoamine neurotransmitters dopamine, serotonin, histamine, and octopamine. Additionally,
recent evidence suggests that VMAT transports the amino acid neurotransmitter GABA (Tritsch,
2012). Many of these neurotransmitters, including dopamine (Andretic et al., 2005; Kume et al.,
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2005), octopamine (Crocker and Sehgal, 2008), serotonin (Yuan et al., 2006), and GABA (Agosto
et al., 2008), have been independently implicated in regulating sleep behavior. We found that
mutants deficient for each of these neurotransmitters displayed increased sleep after reserpine
feeding, suggesting that no single neurotransmitter system accounts for the impact of VMAT
inhibition on sleep. Similarly, Chen et al. (2013) found that circadian rhythms are perturbed in
VMAT

p1

mutants, and rescue of this phenotype requires VMAT in multiple neuronal populations.

In mammals as well, Coulter et al. (1971) demonstrated that the effect of reserpine on sleep
cannot be attributed to reductions in serotonin or norepinephrine. Our findings contribute to a
picture of sleep regulation driven by a robust network of neurotransmission that requires VMAT in
multiple neuronal populations.
Altered VMAT function has previously been studied in the context of many
neuropsychiatric and neurological diseases, including depression, bipolar disorder,
schizophrenia, and Parkinson’s disease (Wimalasena, 2011). These diseases are accompanied
by an increased prevalence of sleep perturbations, although these have not yet been linked to
VMAT. Understanding the role of VMAT in sleep may elucidate the pathophysiology of sleep
perturbations in the disorders noted here, as well as the natural regulation of sleep in healthy flies
and humans.
The potential for screens in Drosophila to identify drugs for human use is high. Although
numerous side effects make reserpine suboptimal as a treatment, more specific inhibitors of
VMAT2 may be tolerated better by patients and improve their use as a sleep aid. The screen
reported here identified a single sleep-promoting drug, but expanded screens could identify many
more potential pharmacotherapies. We used a drug library with known biological targets, which
may have biased the findings toward well-studied pathways. Additionally, a low concentration of
drug was used to reduce lethality, meaning that only drugs with the strongest impacts on sleep
were found. Now that the utility of these screens has been proven, larger screens can be used to
identify other novel modulators of behavior.
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In conclusion, we used a small-molecule screen to discover regulators of sleep
phenotype. Using a genetic approach to confirm one of these drugs, we found that VMAT is
required to establish normal sleep duration and arousal state, presumably by regulating
transmission of several neurotransmitters. The role of genetic background in the expressivity of
the VMAT phenotype highlights the strong effect of developmental compensation on behaviors,
such as sleep, and the importance of targeting pathways acutely in adults to look at adult
behavior. Small-molecule screens in live animals provide a powerful tool for dissecting molecular
mechanisms of adult behavior.
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CHAPTER 2 – Caffeine promotes wakefulness via dopamine
signaling in Drosophila

ABSTRACT
Caffeine is the most widely-consumed psychoactive drug in the world, but our
understanding of how caffeine affects our brains is relatively incomplete. Most studies focus on
effects of caffeine on adenosine receptors, but there is evidence for other, more complex
mechanisms. In the fruit fly Drosophila melanogaster, which shows a robust diurnal pattern of
sleep/wake activity, caffeine reduces nighttime sleep behavior independently of the one known
adenosine receptor. Here, we show that dopamine is required for the wake-promoting effect of
caffeine in the fly, and that caffeine likely acts presynaptically to increase dopamine signaling.
We identify a cluster of neurons, the paired anterior medial (PAM) cluster of dopaminergic
neurons, which are essential for the caffeine response and which show increased activity
following caffeine administration. While previous studies have demonstrated adenosine-mediated
effects of caffeine on post-synaptic dopamine receptors, to our knowledge, this is the first set of
studies implicating the synthesis of dopamine in the arousal-promoting effects of caffeine.

INTRODUCTION
Caffeine is the most widely consumed psychoactive drug in the world. Its popularity is
likely due to its ability to fight drowsiness and promote arousal. In addition, caffeine can reverse
the effects of sleep deprivation on alertness and cognition, as shown in both rats and humans
(Penetar et al., 1993; Alhaider et al., 2010). Despite the ubiquity of caffeine in our food and
drinks, our understanding of how caffeine affects our brains and bodies is relatively incomplete.
The most extensively-studied behavioral effect of caffeine is acute locomotor stimulation,
which has been attributed to antagonism of adenosine receptors. There are four subtypes of
adenosine receptor, and caffeine antagonizes both A2A and A1 receptors in vivo (Fredholm et al.,
2001). Which of these two receptor subtypes is responsible for the motor-stimulating effect,

31

however, is a point of contention (Snyder et al., 1981; Spealman et al., 1988). The effect of
caffeine on sleep has been relatively less well-studied. A2A receptors have been implicated in
the acute wake-promoting effect of caffeine (Huang et al., 2005; Lazarus et al., 2011), but
adenosine receptors do not have an essential role in driving baseline sleep behavior. A1 and
A2A mutant mice, which should mimic receptor antagonism, have no baseline sleep defects
(Stenberg et al., 2003; Huang et al., 2005). A brain-specific deletion of the A1 receptor causes
reduced slow wave brain activity following sleep deprivation, but these mice do not exhibit a
change in the time spent in sleep or wake states (Bjorness et al., 2009). In addition to adenosine
receptors, caffeine has many other biological targets, including GABAA receptors, ryanodine
receptors, glycine receptors, and phosphodiesterases (reviewed in Mustard, 2014). Investigating
the impact on sleep behavior of these other targets may further our knowledge of the effects of
caffeine.
We turn to a powerful genetic model, the fruit fly Drosophila melanogaster, to further
understand how caffeine promotes wakefulness. While Drosophila has proven to be a fruitful
model for uncovering sleep regulatory mechanisms, the action of caffeine in this model is not yet
understood. Flies have one known adenosine receptor, dAdoR. This receptor only shows 30%
sequence similarity to the human adenosine receptors at the amino terminal, but the important
ligand-binding residues are conserved (Dolezelova et al., 2007). Surprisingly, the dAdoR null
mutant responds to caffeine identically to wild type flies, suggesting that caffeine promotes sleep
in Drosophila via adenosine receptor-independent mechanisms (Wu et al., 2009). Because the
behavioral effects of caffeine are similar between flies and humans, understanding the mode of
action in the fly may elucidate novel actions of caffeine in mammals as well.
Here, we show that the wake-promoting effect of caffeine in Drosophila requires the
synthesis of dopamine, a potent wake-promoting neurotransmitter. The modulation of
dopaminergic signaling by caffeine likely occurs presynaptically. In addition, we identify a cluster
of dopaminergic neurons which are essential for the caffeine response. We hypothesize that
caffeine promotes wake by increasing activity of these neurons.
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MATERIALS AND METHODS
Fly Lines
All flies were raised in vials containing molasses food. Wild type iso31 flies (Ryder et al.,
FS±

2004) were used as controls for all experiments. DTHg and DTHg
the Hirsh lab (UVA, Charlottesville, VA). VMAT

p1

flies were shared with us by

mutants were a kind gift of the Krantz lab

1

lo

(UCLA, Los Angeles, CA). Ebony (BSC1658) Dat (BSC3193) and TH-Gal4 (BSC8848) were
ordered from the Bloomington Stock Center (Bloomington, IL). The restricted dopaminergic
drivers TH-C1-Gal4, TH-D1-Gal4, TH-D4-Gal4, TH-F1-Gal4, TH-F2-Gal4, TH-G1-Gal4 were all
generously shared with us by the Wu lab (Johns Hopkins University, Baltimore, MD), and the
other dopaminergic drivers InSite0104-Ga4 and InSite0273-Gal4 were shared by the Clandinin
ts

lab (Stanford University, Stanford, CA). UAS-Shibire flies were a gift of the David Anderson lab
(CalTech, Pasadena, CA). UAS-CaLexA flies were a gift of Dr. Jing Wang’s lab (UCSD, La Jolla,
CA).

Behavioral Assays
To assay sleep behavior, we used the Drosophila Activity Monitoring System (DAMS,
TriKinetcs). 5- to 10-day-old flies were individually monitored in 5 mm glass tubes containing food
composed of 5%sucrose and 2%agar (sucrose/agar food). Activity was monitored for five
o

consecutive days in incubators kept on a 12 hour light/dark schedule at 25 C. Sleep behavior
was analyzed using PySolo software, and sleep bouts were defined at 5 or more minutes of
inactivity (Gilestro and Cirelli, 2009). For all experiments, 10-16 flies were used per treatment
group, sex, and genotype.
For circadian experiments, flies were entrained in DAMS monitors for two days in 12 hour
light-dark cycles and then moved to constant darkness for five days. Circadian rhythms of activity
were determined using ClockLab software (Pfeiffenberger et al., 2010).
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ts

o

For Shibire temperature shift experiments, fly crosses were set and raised at 18 C to
avoid prematurely silencing the neurons. Flies were then loaded into DAMS monitors in
o

incubators set 12 hours light-dark cycles with a temperature of 21 C, which is permissive for the
ts

o

Shibire mutation. The next day, the temperature increased to 30 C, the restrictive temperature,
o

at lights-on. Sleep was assayed during three days at 30 C and averaged across all days.

Drug Feeding
Caffeine (Sigma-Aldrich) was mixed into melted sucrose/agar food at a concentration of
0.5 mg/mL for all experiments except for the dose-response experiment where 0.2, 0.5, and 1
mg/ml were used. L-DOPA (Tocris) was mixed into melted sucrose/agar food at a concentration
of 3mg/ml.

Confocal Microscopy
5- to 10-day-old CaLexA flies were moved from vials containing molasses food to vials
containing either sucrose/agar food or sucrose/agar food with 0.5 mg/ml caffeine. After 24 hours,
flies were anesthetized on ice, and brains were dissected in 1x phosphate-buffered saline (PBS)
containing 0.1% Triton X-100 (PBS-T). Ten brains were dissected per genotype, and all brains
were fixed for 1 hour in 4% paraformaldehyde (PFA; Electron Microscopy Sciences). Brains were
washed in PBS-T and blocked for one hour in PBS-T containing 5% normal donkey serum (NDS;
o

Jackson ImmunoRes). Brains were incubated at 4 C overnight in primary antibody in PBS-T with
5% NDS. CaLexA signal was labeled with 1:1000 dilution of rabbit α-GFP (Life Technologies)
and neuropil was stained with a 1:1000 dilution of mouse α-nc82 (Developmental Studies
Hybridoma Bank). Brains were washed three times with PBS-T and stained for 2 hours with
secondary antibodies in PBS-T with 5% NDS. 1:1000 dilutions were used for α-rabbit AlexaFluor
488 (Invitrogen) and α-mouse AlexaFluor 633 (Invitrogen). Brains were washed three times in
PBS-T and mounted on slides using VectaShield (Vector Laboratories, Inc.). Slides were imaged
on a Leica SP5 confocal microscope with 20x objective and 0.5 µm step size. GFP intensities
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were quantified post-hoc
hoc on a cell
cell-by-cell basis from individual Z-planes
planes using ImageJ software
(Abramoff et al., 2004).

RESULTS
The behavioral response to caffeine requires dopamine synthesis in Drosophila
Similarly to mammals,
Drosophila experience reduced sleep
following caffeine feeding. This
reduction of sleep can be seen in both
male and female flies across a 24
24-hour
light/dark cycle, but the effect is most
robust and reproducible in the dark
(nighttime) phase (Figure 2.
2.1). Wild
type
e (iso31; Ryder et al., 2004) flies
exhibit a dose-dependent
dependent decrease
in nighttime sleep when fed
increasing concentrations of caffeine

Figure 2.1 - Caffeine Reduces Sleep in Drosophila
Sleep profiles for male (a) and female (b) flies
assayed on drug-free
free food (black line) or food
containing 0.5 mg/ml caffeine (blue line). Graphs
depict minutes of sleep per 30 minute sliding window
across a 24-hour
hour period composed of 12 hours of
light (white bar) and 12 hours of dark (black
(
bar).
Error bars show standard deviation.

(Figure 2.2a, d). The 0.5 mg/mL
caffeine concentration produced the largest, most reproducible loss of sleep with no toxic
to
effects,
so this concentration was used for the rest of the experiments reported here.
Evidence from both mammals and Drosophila suggests a role for dopamine signaling in
the effect of caffeine on arousal (reviewed in Chen et al., 2010). However, th
those
ose previous studies
implicate dopamine receptors, which in mammals are known to interact with adenosine receptors,
and do not assay for a requirement of dopamine (reviewed in Xie et al., 2007). We tested the
requirement of dopamine in the caffeine respon
response
se using a transgenic fly line deficient for tyrosine
hydroxylase (DTH), the rate
rate-limiting
limiting enzyme in dopamine biosynthesis. DTH, encoded by the
pale (ple)) gene, is required in peripheral tissue during development, resulting in larval lethality of
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the ple null mutant (Jurgens et al., 1984; Neckameyer et al., 1993). A nervous system-specific
system
FS±

DTH mutant (DTHg

) was created by transgenically expressing a periphery
periphery-specific
specific isoform of
DTH in a ple null
mutantbackground (Riemensperger
FS±

et al., 2011). This DTHg

transgene rescues the viability
defect of the ple mutants, but they
still lack DTH in the nervous
system. Control flies contain a wild
type copy of the DTH coding
sequence in a ple mutant
background (DTHg
DTHg), rescuing
expression in both the nervous
system and peripheral
tissue.
We measured the effect of
chronic caffeine exposure on iso31,
FS±

DTHg, and DTHg

flies by

concomitantly exposing these flies to
Figure 2.2 - The response to caffeine requires
dopamine synthesis in Drosophila
Sleep profiles for female (a) iso31, (b) DTHg, and (c)
DTHgFS± flies on drug-free
free food (black line) or food
containing 0.5 mg/ml caffeine (blue line). Graphs
depict minutes of sleep per 30 minute sliding window
across a 24-hour
hour period composed of 12 hours of light
(white bar) and 12 hours of dark (black bar). (d)
Average number of minutes of sleep per night is plotted
for the three genotypes
es fed either drug
drug-free food or
food containing 0.2, 0.5, or 1 mg/ml caffeine. (e)
Circadian period of free-running
running rest
rest-activity rhythms is
plotted for the same three genotypes fed drug
drug-free food
or food containing 0.5 mg/ml caffeine. Error bars show
standard deviation.
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caffeine-containing
containing food and
monitoring their sleep behavior for five
days. The sleep-reducing
reducing effect of
caffeine was most robust and
reproducible during the dark phase,
so nighttime sleep was quantified for
all experiments. Female iso31 flies

experienced about 160 minutes less sleep during the night when assayed on food containing 0.5
mg/mL caffeine compared to drug-free food (p<0.0001 by 2-way ANOVA with Bonferroni multiple
comparisons) (Figure 2.2a, d). DTHg control flies also showed a decrease in nighttime sleep
when exposed to caffeine, sleeping 86 minutes less than flies fed drug-free food (p=0.0008 by 2FS±

way ANOVA with Bonferroni multiple comparisons) (Figure 2.2b, d). DTHg

flies, on the other

hand, were resistant to the wake-promoting effect of caffeine, sleeping about 650 minutes per
night irrespective of drug treatment (Figure 2.2c, d). While these figures depict data for female
flies,
similar results were observed for males as well (data not shown).
In addition to promoting wake, caffeine lengthens circadian period in both mammals and
insects (Wu et al., 2009; Oike et al., 2011). We monitored rest-activity rhythms of flies in constant
conditions, and found that 0.5 mg/ml caffeine lengthened the circadian period of these rhythms
from 23.8 to 25 hours (p < 0.0001; 2-way ANOVA with Bonferroni multiple comparisons). The
effect of caffeine on DTHg control flies was more modest, lengthening period from 23.5 to 24.1
hours (p = 0.001). The effect of caffeine on circadian period seemed to also require dopamine,
FS±

because the DTHg

flies did not display lengthened period when monitored on caffeine-

containing food (p = 0.99).

Caffeine affects dopaminergic signaling upstream of DTH
We next sought to determine if we could rescue the caffeine response by restoring
dopamine to DTHg

FS±

mutants. DTH catalyzes the conversion of tyrosine to L-DOPA, which is

then converted to dopamine by Dopa decarboxylase (Ddc) (Budnik and White, 1987; Livingstone
FS±

and Tempel, 1983). Despite lacking neural DTH, DTHg

flies can produce dopamine if supplied
FS±

with exogenous L-DOPA. Feeding L-DOPA to iso31, DTHg, and DTHg

flies caused a sleep

decrease, consistent with an augmentation of dopamine signaling in all of these genotypes
(Figure 2.3d). Both iso31 and DTHg flies experienced an even more drastic sleep loss when fed
both L-DOPA and caffeine together, as compared to L-DOPA alone.
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Iso31flies slept 483 minutes per night when fed L-DOPA-containing
containing food, and 362
minutes per night when fed food containing both L
L-DOPA
DOPA and caffeine (p=0.0009 by 2-way
2
ANOVA with Bonferroni multiple comparisons) (Figure 2.3a, b). DTHg flies slept 218 minutes
m
per
night when fed L-DOPA,
DOPA, and 54 minutes per night when fed L
L-DOPA
DOPA and caffeine (p<0.0001)
(Figure 2.3b,
3b, d). Importantly, L
L-DOPA
DOPA feeding did not rescue the caffeine responsiveness of
FS±

DTHg

flies; they slept 297 minutes per night when fed L
L-DOPA
DOPA alone, and 306 minutes per

night when fed L-DOPA
DOPA and caffeine together, a difference which is not significant (p=0.99)
(Figure 2.3c,
3c, d). Because rescue
of dopamine synthesis
downstream of DTH did not
no restore
caffeine response, caffeine likely
modulates dopaminergic signaling
upstream of DTH.
Figure 2.3 - Caffeine affects
dopaminergic signaling
upstream of DTH
Sleep profiles for female (a)
iso31, (b) DTHg, and (c)
DTHgFS± flies on food
containing 3mg/ml L-DOPA
L
(black line) or food containing 3
mg/ml L-DOPA
DOPA and 0.5 mg/ml
caffeine (blue line). Graphs
depict minutes of sleep per 30
minute sliding window across a
24-hour
hour period composed of 12
hours of light (white bar) and 12
hours of dark (black bar).
bar) (d)
Average number of minutes of
nighttime sleep is plotted for
flies fed drug--free food (white
bars), food containing 0.5
mg/ml caffeine (small check
bars), food containing 3 mg/ml
L-DOPA
DOPA (large check bars), or
food containing 3 mg/ml LL
DOPA and 0.5 mg/ml
mg
caffeine
(black bars). Error bars show
standard deviation.
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The response to caffeine is sensitive to neuronal dopamine levels
Dopaminergic signaling can be disrupted not only by blocking biosynthesis, but also by
blocking synaptic release and dopamine inactivation. Synaptic release of dopamine relies on the
transport of dopamine into synaptic vesicles by the vesicular monoamine transporter (DVMAT).
Disrupting this transport with a null mutation
in the DVMAT gene blocks dopamine
signaling, and we found that this mutation
also blocked the wake-promoting
promoting effect of
p1

caffeine. DVMAT null mutants (DVMAT
(
)
outcrossed into an iso31 genetic
ge
background (Nall and Sehgal, 2012) slept
505 minutes per night when fed drug-free
drug
food and 520 minutes per night when fed
food containing 0.5 mg/mL caffeine, a
difference which is not significant (p=0.86)
(Figure 2.4).
Dopamine signaling is also
Figure 2.4 - The response to caffeine
requires synaptic packaging of dopamine
Sleep profiles for female (a) iso31 and (b)
DVMATp1 flies assayed on drug
drug-free food
(black line) or food containing 0.5 mg/ml
caffeine (blue line). Graphs depict minutes of
sleep per 30 minute sliding window across a 24
24hour period composed of 12 hours of light (white
bar) and 12 hours of dark (black bar). (c)
Average number of minutes of nighttime sleep
for flies fed drug-free
free food (white bars) or food
containing 0.5 mg/ml caffeine (bla
(black bars). Error
bars show standard deviation.

regulated by the rate of dopamine
inactivation, which occurs when dopamine
molecules are conjugated to different
functional groups that mark them for
degradation. Dopamine is inactivated and
degraded in glia and neurons by different
pathways. The enzyme Ebony, a β-alanyl

dopamine synthase, inactivates
nactivates dopa
dopamine in glia and the enzyme Dopamine-N--acetyltransferase
(Dat) inactivates dopamine in the nervous system and gut
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1

(Brodbeck et al., 1998; Richardt et al., 2002). Ebony mutants (e ) maintained caffeine response,
with caffeine-fed
fed flies sleeping 122 fewer minutes per night than flies fed drug-free
free food (p=0.006,
lo

2-way
way ANOVA with Bonferroni multiple comparisons) (Figure 2.5b,
5b, d). Dat mutants (Dat ), on the
other hand, were resistant to the effect of caffeine, sleeping about 450 minutes per night
regardless of food caffeine content (p=0.13) (Figure 2.5c,
5c, d). Given that these mutants are
predicted to have higher levels of
presynaptic dopamine, we su
surmise that
maintenance of appropriate dopamine
levels in neurons
is essential for the arousal response to
lo

caffeine. Dat mutants may be unable to
respond to caffeine due to saturated
exocytotic machinery or developmental
compensatory mechanisms. The
importance of maintaining proper
dopamine levels has a precedent in
Drosophila neurobiology, as flies with
either elevated or reduced dopamine
levels show impaired memory retention
(Zhang et al., 2008).

Mapping
apping dopaminergic neurons
required for the response to caffeine
There are many clusters of
dopaminergic neurons in the fly bra
brain,
characterized by location of cell bodies

Figure 2.5 - The response to caffeine requires
proper neuronal dopamine turnover
Sleep profiles for female (a) iso31 and (b) ebony1
and (c) Datlo flies assayed on drug--free food (black
line)
e) or food containing 0.5 mg/ml caffeine (blue
line). Graphs depict minutes of sleep per 30 minute
sliding window across a 24-hour
hour period composed of
12 hours of light (white bar) and 12 hours of dark
(black bar). (d) Average number of minutes of
nighttime sleep for flies fed drug-free
free food (white
bars) or food containing 0.5 mg/ml caffeine (black
bars). Error bars show standard deviation.

and the anatomical targets of axonal
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projections (Mao and Davis, 2009). We silenced subsets of dopaminergic neurons using
ts

ts

restricted Gal4 drivers to express the temperature
temperature-sensitive
sensitive dynamin mutant Shibire (Shi ). At
o

the restrictive temperature, 30 C, the targeted neurons have stalled axonal transport and synaptic
signaling (Kitamoto et al., 2001). We used six restricted dopaminergic Gal4 lines created by the
Wu lab and two others from the InSite
collection (Liu et al., 2012, Gohl et al.,
2011). Six of the Gal4 lines still
permitted a caffeine-induced
induced loss of nighttime
o

ts

sleep at 30 C when driving Shi . One fly line,
ts

TH-F2-Gal4>Shi , had a significant caffeineinduced sleep reduction only in males;
however, the there was a strong trend towards
sleep loss in females (p=0.0639 by ANOVA
with Bonferroni multiple comparisons). One
Gal4 line, InSite0273, prevented a caffeinecaffeine
ts

induced sleep decrease when driving
drivi Shi at
o

30 C in both males and females (Figure 2.6 a,
b). Therefore, this driver defines a group of
dopaminergic neurons which, when silenced,
Figure 2.6 - Mapping dopaminergic
neurons required for the caffeine
response
Average number of minutes of nighttime
sleep for (a) male and (b) female flies
containing various restricted dopaminergic
Gal4 constructs driving expression of
temperature-sensitive
sensitive Shibire (UAS
(UAS-Shits).
Control flies contain the UAS
UAS-Shits transgene
in the absence of a Gal4 driver. Nighttime
sleep is averaged across three nights at the
30oC restrictive temperature on drug
drug-free
food (white bars) or food containing 0.5 mg/ml
caffeine (black bars). Error bars show
standard deviation.

block the wake-promoting
promoting effect of caffeine.

Caffeine causes increased activity of PAM
cluster neurons
The InSite0273 driver line expresses
Gal4 primarily in the Paired Anterior Medial
(PAM) cluster, which is a group of dopaminergic
neurons that projects mostly to the mushroom
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bodies. We monitored the effect of caffeine on the PAM neurons using the CaLexA tool,
t
in which
neural activity-induced
induced elevation of intracellular calcium results in long-term
term green fluorescent
protein (GFP) reporter expression (Masuyama et al., 2012). Representative images showed a
noticeable increase in GFP fluorescence in InSite0273-Gal4
Gal4 labeled cells following 24 hours of
caffeine feeding (Figure 2.7a, b).
This increase in GFP signal was
significant, both in terms of the
number of cells with visible GFP
expression,, as well as the
average GFP intensity for all of
the visible cells in each brain
(Figure 2.7c,
c, d). This suggests
that caffeine ingestion causes
Figure 2.7 - Caffeine causes
increased activity of PAM
cluster neurons
Immunostaining of the CaLexA
signal (GFP, green) and neuropil
(nc82, magenta) in brains of flies
expressing the CaLexA construct
under the control of the 02730273
Gal4 (a-d)
d) and TH-Gal4
TH
(e-h)
drivers.. Flies were fed either
(a,e) drug-free
free food or (b,f)
(b food
containing
ontaining 0.5 mg/ml caffeine for
24 hours prior to dissection and
staining. The GFP intensity was
quantified on a cell-by-cell
cell
basis
in each brain, with
n=20 brains per treatment group.
(c,g)) The average cell intensity
for each brain is plotted for drugdrug
free and caffeine-fed
caffeine
groups.
(d,h)) The number of visible GFPGFP
positive cells in each brain is
plotted for drug-free
drug
and caffeinefed groups. Large horizontal line
reflects the average, and error
bars show standard deviation.
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increased neuronal activity in the PAM cluster neurons.
As a control, we quantified the activity-induced calcium signal in a different set of
dopaminergic neurons, the PPM3 cluster. These neurons form a wake-promoting circuit
projecting to the dFB (Ueno et al., 2012). After 24 hours of caffeine exposure, these flies showed
no increase in GFP signal than flies given drug-free food. This indicates that the effect of caffeine
on neuronal activity is somewhat specific to the PAM cluster and not all dopaminergic or wakepromoting neurons.

DISCUSSION
Many features of human sleep are observed in Drosophila, and the fruit fly has been an
invaluable tool in identifying sleep regulatory mechanisms. As in humans, caffeine treatment in
Drosophila increases wakefulness, lowers arousal threshold, and fragments sleep (Andretic et al.,
2008; Wu et al., 2009; Roehrs and Roth, 2008). While the arousal-promoting effects of caffeine
are beneficial to humans during the day, they can be disruptive to successful sleep at night.
Thus, it is important to identify all the mechanisms through which caffeine affects brain function.
Most effects of caffeine, including promoting arousal, have been studied in the context of
adenosine receptor antagonism. Caffeine can bind mammalian adenosine receptors,
antagonizing A1 and A2a subtypes with equal affinity in vitro and in vivo (Fredholm and
Lindström, 1999; Fredholm et al., 2001). Caffeine also shows a psychomotor profile consistent
with non-specific adenosine receptor antagonism (Karcz-Kubicha et al., 2003). Studies in mice
have implicated adenosine signaling in caffeine-induced arousal, demonstrating that global or
nucleus accumbens-restricted knockdown of A2A receptors blocks the response to caffeine
(Huang et al., 2005; Lazarus et al., 2011). These studies, however, only measured the acute
response to caffeine, measuring wakefulness during a 3-hour window following a single injection
of caffeine in a naïve mouse. This paradigm does not mimic a coffee-sipping human consuming
caffeine, nor does it account for sleep effects on a longer time scale.
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The physiological and behavioral effects of caffeine seem to be dependent on
concentration, mode of administration, and chronic versus acute exposure (Reviewed in Ferré,
2008).

For example, animals show no locomotor response to chronic caffeine administration,

since they rapidly develop tolerance; however, chronic caffeine exposure reduces sleep
persistently (Finn and Holtzman, 1986; Roehrs and Roth, 2008). Indeed, chronic caffeine
administration has very different effects and pharmacology to acute administration (Jacobson et
al., 1996). The divergent effects seen with different administration paradigms support the notion
that caffeine likely has a complex mode of action. While adenosine receptor antagonism may be
involved in acute behavioral changes following caffeine injection, other mechanisms may be at
play in the prolonged effects of caffeine on sleep and arousal. Previously, the wake-promoting
effect of chronic caffeine feeding was shown to be independent of the one known adenosine
receptor in Drosophila (Wu et al., 2009). This finding makes Drosophila a unique model for
studying adenosine-independent mechanisms of caffeine response.
Here, we demonstrate a requirement of the neurotransmitter dopamine for the effect of
caffeine on sleep in Drosophila. We used an ad libitum feeding of caffeine-containing food while
monitoring sleep constantly for five days. We observed a strong reduction of sleep during every
night of caffeine exposure and this effect was dose-dependent. Mutants that do not produce
dopamine, however, were resistant to the wake-promoting effect of caffeine. In addition to
promoting wake, caffeine lengthens the period of circadian rhythms in the bread mold Neurospora
crassa, flies, and mice (Feldman et al., 1975; Wu et al., 2009; Oike et al., 2011). We
FS±

demonstrate that the dopamine-deficient DTHg

flies are also resistant to caffeine-induced

period lengthening. While the effect of caffeine on the DTHg control flies is much more modest
than for iso31 flies, both genotypes do show statistically significant lengthening of circadian
period. The difference in magnitude of caffeine response between these two genotypes may
have to do with differences in expression level or pattern between the endogenous DTH locus in
wild type iso31 flies and the DTH transgene expressed by DTHg flies.
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Previous studies have suggested that dopaminergic signals modulate some clockcontrolled behaviors. One cluster of clock neurons, the large ventral-lateral neurons (lLNvs), are
wake-promoting cells that express the dopamine receptor, dDopR, and receive dopaminergic
inputs that may promote wake in the absence of light (Shang et al., 2011). The Birman lab found
FS±

that dopamine-deficient DTHg

flies are defective in circadian entrainment and phase shifting in

response to dim light cues, however the mechanism and relevant cells for this behavior were not
identified (Hirsh et al., 2010). No previous report has demonstrated an effect of dopamine on the
pace of the circadian clock (Shang et al., 2011). The finding that both the wake-promoting and
period-lengthening effects occur through the same dopaminergic mechanism is surprising and
novel.
Dopamine is known to be a potent wake-promoting neurotransmitter, so we hypothesized
that caffeine promotes wakefulness by enhancing dopaminergic signaling. This was supported
by some studies in Drosophila although these did not examine a role for dopamine synthesis and
release (Andretic et al., 2005; Ganguly-Fitzgerald et al., 2006; Kume et al., 2005). Our data
suggest that caffeine acts presynaptically, upstream of L-DOPA.

This was indicated by the
FS±

experiment showing that L-DOPA could not restore caffeine responsiveness to DTHg

flies even

though it did reduce sleep in these mutants, indicating that they contain both the neural circuitry
and receptors by which dopamine can promote wakefulness. Lack of a response to caffeine is not
due to a floor effect, as the DTHg flies show a strong reduction in sleep with L-DOPA and an
even more marked decrease with the addition of caffeine.
Caffeine has been linked to dopaminergic signaling in mammals; however, this link has
always invoked adenosine receptors, which dimerize with and inhibit dopamine receptors (Salmi
et al., 2005). Interestingly, though, two laboratories found that dopamine levels rise in the brains
of mice after acute caffeine administration (Solinas et al., 2002, Okada et al., 1996). In addition,
increased extracellular dopamine causes caffeine hypersensitivity, as shown in both dopamine
transporter (DAT) mutant mice and DAT (fumin) mutant flies (Wisor et al., 2001; Andretic et al.,
2008). A recent study shows that humans carrying a polymorphism associated with lower
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expression of the dopamine transporter are also hypersensitive to caffeine (Holst 2014). In fact,
almost all known psychostimulants promote arousal by enhancing dopaminergic signaling via
different mechanisms (Nishino et al., 1998). This collection of observations does not suggest a
mechanism, but does imply that the dopaminergic mechanisms at play in Drosophila may be
relevant to humans.
We confirmed that we could block the effect of caffeine on sleep by perturbing other
steps in dopamine signaling as well. Mutants for the vesicular monoamine transporter (DVMAT)
are also resistant to caffeine. These flies cannot package monoamine neurotransmitters,
including dopamine, into presynaptic vesicles, and have depleted tissue dopamine by HPLC
(Simon et al., 2009). Proper dopamine balance also depends on dopamine turnover. The
turnover process is initiated by a few different enzymes, each of which conjugates dopamine
molecules to functional groups that tag them for degradation. In glia, the enzyme ebony
conjugates dopamine to a beta-alanyl group (Hodgetts and Konopka, 1973; Richardt et al., 2003).
Dopamine is also conjugated to N-acetyl group by Dopamine N-Acetyltransferase (Dat)
throughout the nervous system and gut (Brodbeck et al., 1998). Dopamine balance is important
1

for sleep and circadian behavior, supported by the finding that ebony mutants (e ) have disrupted
lo

circadian rhythms of locomotor activity and Dat mutants (Dat ) have an elevated homeostatic
rebound following sleep deprivation (Newby and Jackson, 1991; Suh and Jackson, 2007;
1

lo

Maranda and Hodgetts, 1977). Interestingly, e mutants respond to caffeine, while Dat mutants
do not. This suggests that maintenance of dopamine levels in neurons, not in glia, is essential for
the ability of caffeine to promote arousal.
The Drosophila brain contains many clusters of dopaminergic neurons, which are
characterized by expression of DTH. These clusters are defined by locations of the cell bodies,
as well as the main anatomical targets of their projections (Mao and Davis, 2009). By acutely
silencing subsets of neurons, we identified one group whose signaling is required for caffeineinduced sleep loss.

This group of neurons is defined by the InSite0273-Gal4 driver line, which

expresses primarily in the PAM cluster of neurons (Burke et al., 2012). This cluster of neurons
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primarily projects to the medial portion of the mushroom body beta lobe (Claridge-Chang et al.,
2009). This is consistent with the finding that the DopR dopamine receptor is required in the
mushroom bodies for the caffeine response, suggesting a circuit through which caffeine increases
dopamine signaling (Andretic et al., 2008). Interestingly, previously-defined groups of wakepromoting neurons were dispensable in the caffeine response. Th-D4-Gal4, Th-D1-Gal4, and
TH-G1-Gal4, which promote wake when driving the heat-sensitive cation channel TrpA1, did not
block the wake-promoting effect of caffeine when silenced (Liu et al., 2012). Therefore, the wakepromoting circuit responsible for the caffeine response seems to be distinct from previouslyidentified circuits.
We confirmed that the PAM cluster neurons are indeed modulated by caffeine by
demonstrating that caffeine feeding causes increased neuronal signaling in InSite0273-labeled
cells. For these experiments, we used the CaLexA tool, which translates calcium increases from
sustained neural activity into GFP reporter expression (Masuyama et al., 2012). 24 hours of
caffeine exposure leads to increased calcium-dependent GFP expression in the PAM neurons,
both in terms of average fluorescence intensity per cell and the number of visibly labeled cells per
brain. The InSite0273-Gal4 line expresses in about 130 neurons; however, only between 4 and
22 showed visible activity-dependent GFP expression at baseline, which increases to between 11
and 42 when the flies were fed caffeine. This indicates that only a subset of PAM neurons is
highly active at baseline and is activated by caffeine. Interestingly, silencing cells labeled by the
InSite0104-Gal4 line, which expresses in about 40 of the PAM neurons, is not sufficient to block
the caffeine response (Burke et al., 2012). Additional studies will be required to characterize the
nature of caffeine’s effect on PAM neurons; it is possible that all PAM cells increase activity
slightly following caffeine feeding, pushing a few additional cells above the detection threshold, or
that a distinct group of cells which are not active at baseline respond to caffeine and become
GFP-positive.
How caffeine actually increases dopaminergic signaling is still unclear, and will be an
interesting topic of further study. The ability of caffeine to promote arousal has been found to
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require PKA signaling in the brain, but the relevant neurons have not been identified. It is
possible that caffeine activates PKA in dopaminergic neurons by inhibiting phosphodiesterases
(PDEs) (Fredholm et al., 1999; Ribeiro and Sebastiao, 2010). Another possible mechanism by
which caffeine could increase neuronal activity is by activating ryanodine receptors, which are the
major mediators of activity-induced calcium release in the cell (McPherson et al.,1991). Caffeine
may also be acting on other cell surface receptors, or perhaps on an as-yet-unidentified
adenosine receptor in the fly. Another interesting question for further experiments is why the
PAM cluster neurons are specifically sensitive to caffeine. These neurons may express higher
levels of the sleep-relevant caffeine target molecules, or may simply be the only sleep-modulating
neurons among a broad class of caffeine-sensitive cells. To our knowledge, this is the first set of
studies implicating adenosine-receptor-independent modulation of dopaminergic signaling in the
arousal-promoting effects of caffeine.
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CONCLUSIONS AND FUTURE DIRECTIONS

Many different neurotransmitters, neuropeptides, and neuromodulators have been
implicated in the control of sleep and wake behavior. Here, we have studied on class of
neuromodulators called monoamines, each of which is required for normal sleep behavior (Cirelli,
2009; Nall and Sehgal, 2014). The sleep-relevant pathways for each monoamine
neurotransmitter involve signaling to several different brain regions— the MB, the FB, the PI, and
the ventral lateral neurons. Each of these brain regions receives input from several different
neuromodulators and in turn sends outputs that contribute to sleep, circadian rhythms, and other
behaviors. For example, information about metabolic state, sleep drive, and mating cues must all
be evaluated to dictate whether the fly should be eating, sleeping, or courting.
One mechanistic commonality among all of the monoamines is their packaging into
synaptic vesicles. All of the monoamines rely on the vesicular monoamine transporter (dVMAT),
of which there is only one in Drosophila (Greer et al., 2005). Knocking out dVMAT prevents the
vesicular packaging of dopamine, octopamine, and serotonin, thereby promoting their breakdown
and depleting them from the nervous system. dVMAT-null mutants are defective in exocytotic
aminergic signaling from neurons. They display defects in many different behaviors, which is not
surprising considering the long list of behaviors previously found to be modulated by monoamines
(Simon et al., 2009).
To determine which neurotransmitters are sufficient to drive different behaviors, Chen et
al. (2013) went about restoring dVMAT function to subsets of neurons in an otherwise mutant
background. Using this approach, the authors found that signaling from octopaminergic neurons
alone rescues female fertility, viability, and larval locomotion, whereas either the octopaminergic
neurons or the dopaminergic neurons can restore male fertility. dVMAT only has to be restored to
a single monoamine system, regardless of which one, to restore wild-type startle-induced
hyperactivity. Circadian rhythmicity, which is disrupted in the dVMAT mutant, can be restored by
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expressing dVMAT using any two drivers, be they dopaminergic and octopaminergic,
dopaminergic and serotonergic, or octopaminergic and serotonergic (Chen et al., 2013). This
finding is of particular interest because it illustrates how multiple different neuromodulatory
systems can compensate for the lack of others to establish the very robust phenotype of
behavioral rhythmicity. Loss of rhythmicity is almost never advantageous; therefore, changes in
levels of individual neuromodulators in response to environmental cues should not be able to
easily alter circadian control of locomotion.
In a small molecule screen for sleep-altering compounds, an inhibitor of dVMAT was
discovered as a strong sleep-inducing drug. The dVMAT mutant was found to also have
significantly increased sleep and was resistant to the effects of reserpine. Flies mutant for
biosynthetic enzymes for each monoamine were fed reserpine, but each displayed the increased
sleep caused by the drug. Therefore, no single monoamine system could be identified as the
sleep regulator causing the entire dVMAT mutant sleep phenotype (Nall & Sehgal, 2013). It is
likely that the different monoamine systems work in parallel, with each communicating information
about physiological and environmental situations into a single or multiple sleep circuits, resulting
in finely tuned, contextually appropriate behavior.
In addition to multiple monoaminergic systems creating a robust and layered regulatory
network for behavior, other mechanisms of plasticity can compensate for loss of dVMAT. One
study proposed the importance of developmental compensation by observing that reserpine fed
acutely in adulthood causes hypoactivity whereas dVMAT mutants that have chronically
eliminated exocytotic aminergic signaling display hyperactivity (Simon et al., 2009). The ability of
flies to compensate for reduced monoamine signaling is dependent on genetic background.
dVMAT mutants with a CantonS background show the same elevated sleep phenotype as flies
acutely fed reserpine, but dVMAT mutants in an iso31 genetic background develop relatively
normal sleep behavior in adulthood, even without dopamine, serotonin, octopamine, or other
monoamines (Nall & Sehgal, 2013). The mechanisms by which this compensation occurs are still
unknown, but they are among the important questions in the circuit-wide and systems-wide study
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of behavior. Studying compensatory mechanisms will tell us more about how the many tightly
integrated signaling pathways interact to confer robustness of behavior.
Thus far, research has largely focused on how individual neuromodulators regulate
individual behaviors. However, we are beginning to understand that the signaling molecules are
part of a complex network of interconnected circuits that communicate with each other. To
determine how these circuits interact, we will need to simultaneously study multiple signaling
molecules using combinations of genetic and molecular manipulations. A recent study by Burke
et al. (2012) determined epistasis on a cellular level to demonstrate that octopaminergic control of
short-term appetitive memory actually signals through dopaminergic neurons, which in turn
project to the MB. This approach to elucidating interactions between circuits will prove useful in
determining networks underlying other complex behaviors and perhaps shared networks that link
multiple behaviors. In the case of the VMAT mutant, mapping neurons where VMAT is necessary
and sufficient to drive normal patterns of sleep and wake will be informative. Our work has shown
that in this mutant, baseline sleep, homeostatic rebound, and sleep latency seem to be separable
aspects of sleep behavior which can each be studied to gain a deeper insight into regulatory
circuits which may act separately, convergently, or epistatically.
Various studies have attempted to map the sleep and wake circuits in Drosophila, and
these studies have implicated multiple different brain structures and neuronal populations. In
addition to multiple neurotransmitters contributing to sleep/wake regulation, different brain
structures have also been found to be involved. The pars intercerebralis (PI) relays
octopaminergic wake-promoting signals and the fan-shaped body (FB) seems to be a sleeppromoting brain region that is inhibited by dopaminergic signals (Crocker et al., 2010; Ueno et al.,
2012; Liu et al., 2012). In our studies, we mapped a group of dopaminergic neurons which are
required for the wake-promoting effect of caffeine. These neurons, the PAM cluster neurons, are
distinct from the PPL1 and PPM3 dopaminergic neurons that have been identified as wakepromoting in the past. While the PPL1 and PPM3 project to the fan-shaped body to promote
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wake, the PAM cluster projects primarily to the mushroom body (MB) (Ueno et al., 2012; Liu et
al., 2012; Burke et al., 2012).
The mushroom body has previously been identified as a brain region that promotes
sleep, as ablation of this structure leads to increased arousal (Pitman et al., 2006; Joiner et al.,
2006). However, increasing PKA signaling or neuronal excitability using some mushroom body
Gal4 drivers increases sleep while promoting activation of a different, non-overlapping group of
neurons in the MB causes a sleep decrease, indicating that the MBs likely contain both sleeppromoting and wake-promoting cell groups (Joiner et al., 2006).
The MB expresses dopamine receptors to allow it to respond to signals from neurons
such as the PAM cluster. We hypothesize that the PAM neurons convey wake-promoting signals
to the MB, and these signals are amplified by caffeine. The dopamine type 1 receptor, dDopR,
which is required in the MB for the caffeine response, is the likely recipient of these wakepromoting signals. The MB is a brain region that was previously implicated in learning and
memory. The roles of the MB in sleep and learning may be mechanistically linked. Sleep
deprivation impedes learning in fruit flies, similarly to more complex animals, and this decrement
is exacerbated by drugs that decrease dopamine signaling and by mutation of dDopR (Seugnet et
al., 2008). On the other hand, increasing dDopR signaling, either by feeding agonists or by
overexpressing the receptor in the MBs, was able to rescue learning and memory after sleep
deprivation as effectively as recovery sleep (Seugnet et al., 2008). Caffeine can also reduce
cognitive impairment following sleep deprivation, further underscoring that this dopaminergic
innervation of the MB is targeted by caffeine (Alhaider et al., 2010).
In addition to sleep affecting learning and memory, learning also affects sleep. Flies
appear to modulate the amount of sleep they get depending on prior waking experience; flies
exposed to a socially enriched environment sleep more than those that are individually housed.
Context-dependent sleep change is disrupted by either augmenting or impeding dopaminergic
signaling (Ganguly-Fitzgerald et al., 2006). Further research is required to understand the true
nature of the connection between sleep and learning and the extent to which sleep circuits and
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learning circuits overlap. Determining the specific MB neurons that express dopamine receptors
and mapping their inputs will be useful in dissecting the various behavioral roles for the MB. New
tools are available to assist in this undertaking, including restricted Gal4 lines that express in
subsets of MB neurons. These Gal4 lines can be used to monitor and alter the behavior of these
cells by driving expression of biosensors or modulators of neuronal activity (Pech et al., 2013).
In addition to the PI, FB, and MB, an increasing body of evidence is also implicating the
circadian clock neurons in regulation of sleep and wake behavior. Originally, it was thought that
the circadian and homeostatic control of sleep occurred via separate mechanisms and that
circadian clock neurons only conveyed time-of-day information to downstream circuits (Borbély,
1982). It is now clear that clock neurons can receive modulatory inputs themselves that may
modulate sleep and wake behavior in response to cues besides the normal zeitgebers of light and
temperature. One group of central clock neurons, the large ventral lateral neurons (-lLNvs), are
light-sensitive wake-promoting cells that express receptors for many different internal
neuromodulatory molecules (Shang et al., 2011). Histaminergic control of sleep maps to the clock
neurons; expression of HisCl1 in these cells is necessary and sufficient for normal sleep behavior
(Oh et al., 2013). An earlier anatomical study identified histaminergic projections from extraocular
eyelet photoreceptors to the ventral lateral neurons, which could be the wake-promoting
histaminergic circuit (Hamasaka & Nässel, 2006). The serotonin receptor d5-HT1B is expressed
in clock cells in the brain, where it likely acts to modulate circadian entrainment (Yuan et al.,
2005). However, it is also expressed in the MBs and PI, where it could potentially modulate the
sleep circuit on the basis of light and circadian cues. The lLNvs also respond to octopamine by
increasing cAMP levels in the dark, and sensitivity of these cells to octopamine is under clock
control (Shang et al., 2011).
The responsiveness of the lLNvs to many different inputs makes them an attractive
candidate for future studies on the consolidation of internal and external cues into a single
behavioral program. Indeed, some previous studies have established a precedent for clock cell
involvement in integration of environmental cues and cellular and molecular context to coordinate
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sleep and wake behavior at appropriate times and in appropriate situations. For example, the
lLNvs promote wake in a dopamine-independent manner in the light phase, but respond to
dopamine in the night (Parisky et al., 2008; Shang et al., 2008; Sheeba et al., 2008). Light
suppresses dopamine’s wake-promoting effects by upregulating inhibitory dopamine receptors
(dD2R) in the lLNvs (Shang et al., 2011). Another study showed that clock cells are involved in
prioritizing sleep and foraging behavior, indicating that the clock genes clock and cycle are
required for the suppression of sleep behavior in starvation conditions (Keene et al., 2010). In
our studies, we found that caffeine can not only suppress sleep, but can lengthen the circadian
period, and that these effects are both dependent on dopamine. It is possible that, while the
effect on sleep maps to neurons projecting to the MB, that the period-lengthening effect may act
through dopaminergic neurons projecting to the clock cells. This mechanism may be relevant to
mammalian systems as well, since activation of dopamine type 1 receptors has been shown to
alter clock gene expression, indicating functional interactions of dopamine signaling with clock
cells (Imbesi et al., 2009). Future experiments will need to map the dopaminergic neurons
responsible for the circadian caffeine effect and query whether dopamine receptors in clock cells
are required.
Receptors that receive monoaminergic inputs are usually G-protein coupled receptors
(GPCRs; Marraziti et al., 2009). These traverse the membrane and couple ligand binding to
intracellular signaling by activating different G-proteins. Most of these receptors either activate or
inhibit adenylate cyclase, which produces cyclic adenosine monophosphate (cAMP; Uzzan and
Dudai, 1982; Nall and Sehgal, 2014). Among other signaling cascades, cAMP activates protein
kinase A (PKA), which in turn activates the transcription factor cAMP response element-binding
protein (CREB; Lonze and Ginty, 2002). This signaling pathway is essential for regulating sleep
and wake behavior, with CREB mutant mice showing an increase in time spent in non-rapid eye
movement (NREM) sleep and a decrease in time spent awake (Graves et al., 2003). Consist with
a wake-promoting role for CREB, acute inhibition of CREB signaling in Drosophila causes
increased homeostatic rebound following sleep deprivation (Hendricks et al., 2001). Conversely,
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expressing a constitutively-active form of PKA in all neurons results in a marked reduction of
nighttime sleep (Joiner et al., 2006). More focused studies have shown that PKA signaling in the
MB underlies the control of sleep and wake by that brain structure (Joiner et al., 2006). PKA
signaling in the PI is responsible for the control of sleep by octopamine (Crocker and Sehgal,
2008). In addition, blocking PKA signaling acutely in all neurons using a pan-neuronal inducible
Gal4 (elav-Geneswitch) increases the number of minutes of sleep per day (Wu et al., 2009).
Interestingly, blocking PKA acutely using a mushroom-body-specific inducible Gal4 (MBGeneswitch) did not cause a change in sleep behavior (Wu et al., 2009).
PKA signaling is required for the ability of caffeine to promote wakefulness in Drosophila.
This PKA requirement does not map to the mushroom bodies, however, since blocking PKA
signaling using MB-Geneswitch does not prevent the wake-promoting effect of caffeine (Wu et al.,
2009). Interestingly, the dopamine receptor dDopR is required in the mushroom body for the
response to caffeine, and this receptor is coupled to adenylate cyclase (Sugamori et al., 1995). It
is possible that the regions of the mushroom body receiving the dDopR1-mediated wakepromoting caffeine signal are not targeted by MB-Geneswitch or that dDopR1 couples to a
different second messenger cascade in the MB as has been observed in the other Drosophila
type 1 dopamine receptor dDopR2 and in mammals (Reale et al., 1997; Beaulieu et al., 2011).
The requirement of PKA signaling in non-MB neurons suggests that perhaps this signaling
molecule is required in a different step of the caffeine-sensitive circuit. We find that calcium
release is increased in the MB-projecting PAM neurons following caffeine feeding, but further
experiments will be required to demonstrate whether cAMP/PKA signaling is also upregulated in
these cells. In addition, it will be interesting to observe whether inhibiting PKA signaling in this set
of cells can block the caffeine response.
Caffeine increases PKA activation and CREB phosphorylation in the brains of mice,
suggesting shared mechanisms with Drosophila (Zeitlin et al., 2011). Increases in PKA activation
may be attributable to inhibition of cAMP-degrading phosphodiesterases or perhaps to direct
interactions with adenylate cyclase-interacting receptors. Another similarity between work done
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in Drosophila and mammalian systems is the observation of impacts on dopaminergic signaling,
such as increases in extracellular dopamine, following caffeine administration (Solinas et al.,
2002, Okada et al., 1996). Even caffeine-induced dopamine release has been attributed in
mammals to antagonism of adenosine receptors – in this case, presynaptic adenosine receptors
which inhibit dopamine autoreceptors. However, it is also possible that the presynaptic action of
caffeine in mammals is adenosine-receptor-independent and shares the same mechanisms we
observe in Drosophila. Indeed, adenosine-receptor-independent effects of caffeine have been
described; identical aversive and appetitive responses to caffeine are observed in both wild type
mice and mice lacking both A1 and A2A adenosine receptors (Sturgess et al., 2010).
Activation of ryanodine receptors may be another physiologically-relevant caffeine action,
as ryanodine receptor type 3 mutants have attenuated dopamine release following caffeine
administration (Wan et al., 1999). Ryanodine receptor activation may underlie the increases in
calcium signaling that we observed in the PAM cluster neurons in Drosophila. Mobilization of
calcium stores by ryanodine receptors triggers dopamine release in mammals, and ryanodine
receptor activation can lead to circadian clock phase shifts (Ding et al., 1998; Patel et al., 2009).
It is possible that these effects occur in Drosophila as well, and may explain the link between
neuronal activity, dopaminergic signaling, sleep, and circadian period. Further studies will be
required to determine the sleep-relevant caffeine targets in both mammals and Drosophila,
whether it be PDE inhibition, ryanodine receptor activation, direct dopamine receptor interactions,
or some other mechanism. Discovering the pathways by which caffeine can promote wake will
also inform us about wake-promoting signaling pathways and neuronal circuits that may yet be
unidentified.
In the combined experiments of this document, we have demonstrated an importance of
multiple interacting neurotransmitter systems in establishing various aspects of baseline sleep
behavior and of presynaptic modulation of these systems by pharmacological agents that change
sleep/wake patterns. Acute blockade of synaptic transport of monoamines causes increased
sleep; however, chronic lack of dVMAT can be bypassed by other mechanisms, demonstrating
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how plastic the neuronal controls of this essential behavior can be. We also demonstrated that
caffeine can promote wake by upregulating dopaminergic signaling presynaptically, which has not
yet been demonstrated. In addition, we showed that the relevant caffeine-sensitive neurons
belong to a cluster that had previously not been shown to be involved in the regulation of sleep
and wake. Both of these bodies of work highlight the power of acute pharmacological
approaches to discovering the regulation of behavior in adulthood. They also both underscore
the myriad parallel and interacting pathways that regulate sleep. It is still not clear how the
various sleep pathways interact, and what is the relative contribution of the various monoamine
neurotransmitters – dopamine, serotonin, octopamine, and histamine – as well as the multiple
sleep-regulatory brain structures – the PI, FB, MB, and lLNvs. Whether these circuits converge
spatially and how they can turn a complex body of contextual information into a unified behavioral
program are still open questions. Studying how these different circuits are prioritized in different
environmental contexts or in response to different stimuli will be an essential next step in
determining the purpose of this apparent redundancy. This work will contribute enormously to our
understanding of how we maintain the behavioral plasticity necessary for survival in an everchanging, unpredictable world.
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